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Invasive	 infections	 due	 to	 group	 A	 Streptococcus	 (GAS)	 advance	 rapidly	 causing	 tissue	
degradation	 and	 unregulated	 inflammation.	 Neutrophils	 are	 the	 primary	 immune	 cells	 that	





the	 presence	 of	 intracellular	 neutrophil	 proteins	 via	 immunoblot,	 including	 caspases,	 where	










Infection	 with	 either	 GAS	 strain	 induced	 expression	 of	 inflammatory	 caspases-1	 and	 -4	 in	










different	 emm-type,	 share	 similarities.	 Hence,	 the	 neutrophil	 response	 to	 GAS	 was	 further	
characterised	 in	 response	 to	 two	 emm1	 isolates;	 5448	 (isolated	 form	 invasive	 infection)	 and	








during	the	early	stage	of	 infection	(≤24	h),	 though	 inflammatory	monocytes	(iMOs)	were	also	
detected.	Both	neutrophils	and	iMOs	die	rapidly	in	response	to	GAS	infection	(≤24	h)	and	activate	
inflammatory	caspases	at	the	site	of	infection.	Increased	cytokine	release	was	observed	due	to	
5448AP,	 including	 the	 release	 of	 IL-1β.	 Collectively,	 NS88.2	 (emm98.1)	 and	 5448AP	 (emm1)	
promote	an	inflammatory	neutrophil	phenotype,	where	increased	inflammation	and	ineffective	
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Streptococcus	 pyogenes	 (Group	 A	 Streptococcus,	 Group	 A	 Streptococci,	 GAS)	 is	 a	 cause	 of	
superficial	 epithelial	 infection	 and	 life	 threatening	 disease	 in	 humans	 (Walker	 et	 al.,	 2014).	
Invasive	 infections	 caused	 by	 GAS	 are	 characterised	 by	 unregulated	 inflammation	 and	 tissue	







exploring	 the	 effects	 of	 GAS	 isolated	 from	 invasive	 disease	 upon	 other	 aspects	 of	 neutrophil	
function.	Neutrophils	use	 their	 stored	granules	 and	 reactive	oxygen	 species	 (ROS)	 to	degrade	
phagocytosed	bacteria,	and	hence	neutrophil	function	can	significantly	influence	the	resolution	
of	infection	(Mortaz	et	al.,	2018).	Though	they	are	essential	for	bacterial	defence,	neutrophils	can	




cells	 by	 GAS	 promotes	 bacterial	 survival,	 yet	 can	 lead	 to	 increased	 disease	 severity	 (Norrby-
Teglund	and	Johansson,	2013).	Here,	the	literature	has	been	reviewed	to	outline	current	evidence	



































induction	 of	 auto-immune	 disease	 due	 to	 recurrent	 infection	 and	 severe	 invasive	 infections	
(Cunningham,	 2000,	 Ralph	 and	 Carapetis,	 2013,	Walker	 et	 al.,	 2014),	 although	 asymptomatic	
carriage	on	 epithelial	 surfaces	 such	 as	 the	 skin	and	 throat	 is	 common	and	 can	go	undetected	
(Ekelund	et	al.,	2005).	Transmission	is	predominantly	understood	to	occur	through	person-to-
person	contact	(skin-to-skin,	respiratory	droplets	or	saliva)	which	can	be	increased	in	crowded	
living	 spaces	 that	 may	 also	 provide	 limited	 access	 to	 hygiene	 facilities	 (Kaplan	 et	 al.,	 1971,	
Kreikemeyer	 et	 al.,	 2004,	 Österlund	 and	 Engstrand,	 1997,	 Walker	 et	 al.,	 2014).	 Nosocomial	




almost	 every	 strain	 and	extends	 from	 the	 cell-wall	 as	an	α-helical	 coiled-coil	 (Fischetti,	1989,	



















and	 Prevention	 (CDC,	 https://www.cdc.gov/streplab/groupa-strep/emm-background.html).	
There	is	a	strong	correlation	between	M	type	and	emm-type	(Facklam	et	al.,	1999),	though	the	
GAS	emm-typing	method	now	defines	>240	types	and	subtypes	(Bessen	et	al.,	2018,	Smeesters	et	




each	 cluster	 representing	 functionally	 distinct	 groups	 (Sanderson-Smith	 et	 al.,	 2014).	 Full	
genomic	sequencing	is	becoming	a	standard	for	bacterial	characterisation	due	to	the	high	levels	
of	 information	 to	be	gained	from	whole	genome	sequencing.	A	standardised	method	of	 typing	
from	 genomic	 data	 has	 been	 developed	 (CDC,	 https://www.cdc.gov/streplab/groupa-

















and	 SpeC	 play	 an	 important	 role	 in	 disease	 development	 (Cunningham,	 2000,	 Ferretti	 et	 al.,	




infection	 among	 children	 is	 very	 common	 (Cole	 and	 Gazewood,	 2007).	 The	 World	 Health	
Organisation	estimates	that	in	2005	there	were	111	million	prevalent	skin	epithelia	infections	
due	to	impetigo/pyoderma	(Carapetis	et	al.,	2005,	World	Health	Organisation,	2005).	GAS	is	a	
common	 cause	 of	 impetigo,	 where	 infection	 often	 occurs	 in	 conjunction	 with	 Staphylococcus	
aureus	(Bowen	et	al.,	2014,	Feingold,	1993).	Though	a	higher	global	burden	of	impetigo	can	be	
attributed	 to	 S.	 aureus	 (Bisno	 and	 Stevens,	 1996),	 the	 disease	 burden	 in	 tropical	 climates	 is	
predominantly	due	to	GAS	(Carapetis	et	al.,	2005,	Mahe	and	Hay,	2005).	Skin	barriers	that	are	







as;	 acute	 rheumatic	 fever	 (ARF),	 rheumatic	 heart	 disease	 (RHD),	 acute	 poststreptococcal	
glomerulonephritis	 (APSGN)	 and	 controversially	 paediatric	 autoimmune	 neuropsychiatric	
disorders	associated	with	streptococcal	infection	(PANDAS)	(Cunningham,	2008,	Henningham	et	
al.,	 2012,	Walker	 et	 al.,	 2014).	 ARF	may	 develop	 following	 superficial	 GAS	 infection	 and	 is	 a	



















which	 can	 result	 from	 deep	 penetrating	 injuries,	 burns,	 trauma	 or	 surgery.	 Invasive	 GAS	



























activation,	 cytokine	production	 and	 chemokine	 release	 that	 contribute	 to	 the	advancement	 to	
STSS	(Lappin	and	Ferguson,	2009).	Hypotension,	multiple	organ	failure	and	systemic	toxicity	are	
the	results	of	STSS	and	are	attributed	to	the	ability	of	GAS	superantigens	to	bypass	normal	major	
histocompatibility	 complex	 antigen	 processing	 restriction	 (Lappin	 and	 Ferguson,	 2009,	






















15%	 of	 school	 aged	 children	 and	 4-10%	 of	 adults	 suffer	 from	 GAS	 pharyngitis	 each	 year	





children	 over	 10	months	did	 not	 observe	 said	 tissue	 tropism	 (Campbell	 et	 al.,	 2020),	 though	
different	results	may	be	observed	in	different	regional	contexts.	It	must	also	be	noted	that	GAS	
populations	 are	 extensively	 heterogenetic	 due	 to	 recombination	 events,	 with	 the	 largest	
phylogenetic	study	to	date	unable	to	correlate	lineages	to	clinical	association	(Davies	et	al.,	2019).	






















and	 “emm3”	 (title/abstract)	 and	 “emm4”	 (title/abstract)	 and	 “emm12”	 (title/abstract)	 and	 “emm28”	
(title/abstract),	shown	per	year	(National	Center	for	Biotechnology	Information,	2021).	





commonly	 associated	 with	 M1,	 M3,	 M12	 and	 M28	 serotypes	 (Metzgar	 and	 Zampolli,	 2011).	
Additionally,	 more	 recent	 investigation	 has	 also	 identified	 that	 emm1,	 emm3,	 emm4,	 emm6,	
































(Musser	 et	 al.,	 1995).	 In	 particular,	 GAS	 subtype	 M1T1	 is	 frequently	 isolated	 from	 various	
infection	types	in	urban	settings	and	global	dissemination	has	been	reported	(Ato	et	al.,	2008,	
Cleary	 et	 al.,	 1992,	 Cole	 et	 al.,	 2011,	 Sumby	 et	 al.,	 2005).	 Most	 concerning	 however,	 is	 its	
association	with	life	threatening	diseases	such	as	NF,	STSS	and	sepsis	(Aziz	et	al.,	2010,	Aziz	and	
Kotb,	2008,	Cole	et	al.,	2011).	Due	to	its	prevalence	and	persistence	in	invasive	disease	globally,	
M1T1	 GAS	 has	 been	 a	 significant	 focus	 of	 research	 on	 invasive	 disease	 mechanisms	 and	
therapeutic	development.	
1.3.5 Oceanic	epidemiology	
In	 the	 Oceanic	 Region	 GAS	 disease	 is	 endemic	 in	 some	 Pacific	 Island,	 ‘top	 end’	 Aboriginal	
Australian	 and	Māori	 populations	 (Clucas	 et	 al.,	 2008,	 Le	Hello	 et	 al.,	 2010,	May	 et	 al.,	 2016,	
McDonald	et	al.,	2008).	Constant	and	recurrent	skin	and	pharyngeal	infection	in	these	regions	
underlie	the	highest	global	rates	of	autoimmune	sequelae	(Le	Hello	et	al.,	2010,	McDonald	et	al.,	
2006,	McDonald	 et	 al.,	 2007,	McDonald	 et	 al.,	 2008,	Milne	 et	 al.,	 2012a,	Milne	 et	 al.,	 2012b).	
Furthermore,	 while	 infection	 rates	 of	 2-3	 per	 100,000	 are	 reported	 in	 high	 income	 settings	
(Lamagni	et	al.,	2008,	O'Grady	et	al.,	2007,	O'Loughlin	et	al.,	2007,	Sharkawy	et	al.,	2002),	some	
Aboriginal	 Australian	 and	 Pacific	 Island	 populations	 suffer	 rates	 of	 13.2-82.5	 per	 100,000	
(Carapetis	et	al.,	1999,	Norton	et	al.,	2004,	Whitehead	et	al.,	2011)	and	9.6-11.6	per	100,000	(Steer	
et	 al.,	 2008,	 Steer	 et	 al.,	 2009a)	 respectively	 (Walker	 et	 al.,	 2014).	 This	 increased	 burden,	
especially	 in	 Australia,	 highlights	 significant	 social	 inequity	 within	 affected	 communities	 as	
overcrowded	accommodation,	poverty	and	limited	access	to	health	care	are	contributing	factors	






















therapy	 is	 an	 essential	 part	 of	 treatment,	where	high	doses	of	 penicillin	 and	 clindamycin	are	


















is	 essential.	 The	 idea	 of	 novel	 treatments	 targeting	 inflammatory	 mediators	 have	 been	
hypothesised	 for	use	during	 sepsis	 (Katsenelson	 et	 al.,	 2019),	 and	 could	be	applicable	during	




The	 innate	 immune	 system	 combats	 infection	 and	 tissue	 injury,	 and	 in	 turn	 influences	
inflammation.	 It	 provides	 a	 rapid,	 non-specific	 defence	 where	 epithelial	 cells,	 neutrophils,	
macrophages,	natural	killer	(NK)	cells	and	dendritic	cells	(DCs)	all	play	a	role	during	the	immune	
response	 to	 GAS	 infection	 (Goldmann	 et	 al.,	 2005,	 Goldmann	 et	 al.,	 2004,	 Loof	 et	 al.,	 2007,	
Mishalian	 et	 al.,	 2011,	 Zinkernagel	 et	 al.,	 2008).	 These	 cells	 drive	 a	 coordinated	 response	 to	
phagocytose	bacteria,	release	inflammatory	mediators,	produce	antimicrobial	peptides	(AMPs)	
and	undergo	cell	death	in	order	to	invoke	an	appropriate	immune	response.	The	host-pathogen	
interactions	 of	 the	 innate	 immune	 system	 are	 described	 here,	 outlining	 important	 elements	
relevant	to	GAS	infection.	
1.4.1 Pathogen	recognition	
The	 innate	 immune	 system	 may	 become	 activated	 due	 to	 the	 presence	 of	 invading	 bacteria	
through	the	binding	of	conserved	non-self	and	self-molecules	to	pattern	recognition	receptors	
(PRRs)	on	 the	cell-surface	of	 leukocytes.	PRRs	detect	common	(non-self)	pathogen-associated	
molecular	 patterns	 (PAMPs)	 that	 are	 often	 structural	 or	 essential	 components	 for	 bacterial	






endogenous	 (self)	 danger-associated	 molecular	 patterns	 (DAMPs),	 alerting	 the	 system	 to	
damaged	or	dying	host	cells	(Roh	and	Sohn,	2018).	Common	DAMPs	are	adenosine	triphosphate,	
cytokines,	 cytoplasmic	 and	 nuclear	 proteins	 (Newton	 and	 Dixit,	 2012,	 Roh	 and	 Sohn,	 2018).	
Binding	of	PAMPs	and	DAMPs	to	PRRs	cascades	signalling	for	production	and	release	of	cytokines	
and	 chemokines,	 promoting	 immune	 cell	 recruitment.	 Though	 much	 is	 known	 about	 PRRs,	
























multifaceted	 process.	 Further	 contributing	 to	 the	 complexity	 of	 immune	 recognition	 of	 GAS,	
immune	 cell	 activation	 by	 GAS	 has	 also	 been	 demonstrated	 independently	 from	 the	 three	
predominate	TLRs	(2,	4	and	9)	(Gratz	et	al.,	2008).	
Immune	cell	recognition	of	GAS	can	also	occur	intracellularly	through	non-TLR	pathways	using	




transduction,	 transcriptional	 activation	 and	 cell	 death	 (Kersse	 et	 al.,	 2011,	 Kim	 et	 al.,	 2016).	
Inflammasome	 formation	 is	 important	 in	 the	 inflammatory	 death	 pathway	 pyroptosis	 and	




where	both	 haemolytic	 exotoxin	 streptolysin-O	 (SLO)	 and	 the	M1	protein	 are	have	 also	been	















et	 al.,	 2012,	 Wu	 et	 al.,	 2015,	 Wu	 et	 al.,	 2016,	 Zinkernagel	 et	 al.,	 2012),	 which	 releases	 inflammatory	
cytokines.	Activation	of	macrophages	can	also	occur	via	TLR8	detection	of	GAS	RNA	(Eigenbrod	et	al.,	2015)	









The	 release	 of	 cytokines	 and	 chemokines	 following	 pathogen	 recognition	 recruits	 additional	
immune	 assistance	 to	 an	 area	 of	 infection.	 Inflammation	 encourages	 the	 recruitment	 of	
leukocytes	 to	 an	 area,	 facilitated	 by	 increased	 blood	 flow	 and	 symptomatically	 causing	 heat	
production,	 redness	and	swelling	at	the	site.	During	 infection,	epithelial	cells	are	often	 first	 to	






al.,	2006).	Upon	the	arrival	of	 immune	cells	at	 the	site	of	 infection,	macrophages	and	DCs	are	
thought	 to	 take	 the	predominant	role	controlling	 inflammatory	signalling.	 In	response	 to	GAS	





producers	 (Tecchio	 et	 al.,	 2014),	 even	 though	 they	 are	 abundant	 at	 sites	 of	 GAS	 infection	
(Edwards	 et	 al.,	 2018).	 Although	 many	 cytokines	 act	 to	 recruit	 neutrophils,	 neutrophils	
themselves	have	also	been	shown	to	release	IL-8	(Uchiyama	et	al.,	2015),	TNF-α,	IL-6	and	IL-1β	
(Tsatsaronis	et	al.,	2015)	during	GAS	infection.	DCs	link	the	innate	and	adaptive	branches	of	the	
immune	 system,	 releasing	 TNF-α,	 IL-6	 (Fieber	 et	 al.,	 2015)	 and	 IL-12	 (Loof	 et	 al.,	 2008)	 in	









and	 leukocyte	 recruiters	 and	 can	 even	 induce	 cell	 death	 (Newton	 and	 Dixit,	 2012).	 Though	
mortality	during	invasive	GAS	infection	is	often	associated	with	high	amounts	of	TNF-α	release	
(Norrby-Teglund	et	 al.,	 2000),	 it	 is	 also	 essential	 for	 an	 appropriate	 immune	 response	 in	 vivo	














IL-1	 receptor	 reduces	 neutrophil-driven	 inflammation	 but	 increases	 susceptibility	 to	 GAS	
infection	(Hsu	et	al.,	2011,	Lin	et	al.,	2015),	highlighting	the	importance	of	the	IL-1	receptor	in	









DAMPs	and	 inflammatory	mediators	by	 infected	or	damaged	host	cells	aids	 in	phagocytic	cell	















enzymatic,	 antimicrobial	 or	 oxidative	 activity	 (Mayadas	 et	 al.,	 2014,	 Nordenfelt	 and	 Tapper,	
2011).	




over	 30	 molecules	 circulating	 in	 blood,	 is	 an	 additional	 pathogen	 surveillance	 mechanism	

















concentrations	 (neutropenia)	 or	 hindrance	 of	 regular	 function	 result	 in	 an	 increased	
susceptibility	 to	 infections.	For	patients	with	neutropenia,	even	a	minor	 infection	can	present	
significant	risk	as	 the	mounted	 immune	response	 is	not	strong	enough	to	successfully	clear	a	
pathogen.	 Effective	 neutrophil	 function	 is	 essential	 for	 clearing	 GAS	 infection.	 In	 a	 chronic	
granulomatous	disease	mouse	model	of	GAS	infection,	in	which	the	oxidative	burst	potential	of	
neutrophils	is	reduced	(Nguyen	et	al.,	2017),	increased	mortality	is	observed	during	GAS	infection	
(Saito	 et	 al.,	 2001).	 Recent	 research	 has	 observed	 a	 subpopulation	 of	 ‘primed	 neutrophils’	
(approximately	10%	of	total	neutrophils)	in	both	mice	and	humans	(Fine	et	al.,	2019).	Primed	
neutrophils	in	circulation,	defined	by	cluster	of	differentiation	(CD)63high,	CD66ahigh	and	CD11bhigh	
expression,	 are	 thought	 to	 be	 the	 first	 responders	 to	 acute	 inflammation,	 and	 although	
neutropenia	may	present	in	cases,	the	level	of	primed	neutrophils,	not	total	neutrophils,	dictates	
ability	to	fight	infection	(Fine	et	al.,	2019).	These	new	findings	add	an	additional	complexity	to	
immune	 cell	 characterisation	 but	 collectively	 help	 to	 further	 identify	 the	 important	 role	
neutrophils	play	in	innate	immune-mediated	defence.	
Neutrophils	 use	 oxygen-independent	 and	 oxygen-dependant	mechanisms	 to	 combat	 bacterial	
pathogens.	Following	neutrophil	phagocytosis,	bacteria	 in	the	phagosome	are	challenged	with	
strong	 cytotoxic	 molecules	 as	 they	 undergo	 fusion	 with	 pre-stored	 cytoplasmic	 granules	
(azurophilic,	 secondary	or	specific)	 that	contain	enzymes,	antimicrobials	and	oxidants	 (Hirsch	
and	 Cohn,	 1960).	 Granules	 are	 present	 in	 high	 abundance	 in	 neutrophils	 and	 are	 extremely	
heterogeneous.	They	contain	molecules	such	as	but	not	limited	to;	neutrophil	elastase,	cathepsin	
G,	proteinase	3,	defensins,	 lysozyme,	myeloperoxidase,	collagenase,	gelatinase,	 lactoferrin	and	
LL-37	 (Borregaard	 et	 al.,	 2007,	Mayadas	 et	 al.,	 2014).	 The	 abundance	 of	 enzymes	 and	AMPs	
contained	within	neutrophil	granules	are	just	one	of	the	reasons	they	are	considered	the	most	
efficient	phagocyte	(Lim	et	al.,	2017).	These	molecules	collectively	cause	damage	to	the	bacteria	
















the	 production	 of	 ROS	 in	 the	 phagosome	 can	 result	 in	 intracellular	 and	 extracellular	 release	
(Nguyen	 et	 al.,	 2017).	 Additional	 to	 the	 antimicrobial	 potential	 of	 ROS,	 their	 production	 can	
further	induce	degranulation	(Vorobjeva	et	al.,	2017),	release	of	neutrophil	extracellular	traps	
(NETs)	(Björnsdottir	et	al.,	2015),	production	of	cytokines	(Naik	and	Dixit,	2011)	and	induction	
of	 neutrophil	 apoptosis	 (Lundqvist-Gustafsson	and	 Bengtsson,	 1999).	 Though	 intended	 to	 be	

























cells	 such	 as	neutrophils.	 Intrinsic	 activation	of	 apoptosis	 can	occur	due	 to	neutrophil	 age	or	
stress,	where	B-cell	lymphoma	2-associated	X	protein	interacts	with	the	mitochondria	to	reduce	
membrane	 potential	 while	 releasing	 cytochrome	 c,	 which	 in	 turn	 binds	 apoptosis	 protease	
activating	 factor	 1.	 Oligomerisation	 of	 apoptosis	 protease	 activating	 factor	 1	 forms	 the	
apoptosome	 and	 activates	 caspase-9,	 cascading	 the	 cleavage	 of	 caspase-3	 then	 caspase-7	 to	




occurs	 following	 binding	 to	 Fas	 ligand	 (CD95L),	 TNF-α	 receptor	 and	 TNF-related	 apoptosis-
inducing	 ligand.	Both	 the	 subsequent	death	domains	Fas-associated	death	domain	and	TNF-α	
receptor-associated	death	domain	that	form	result	in	the	activation	of	caspase-8	(Fox	et	al.,	2010).	
Apoptosis	coincides	with	inflammatory	pathways	here,	as	activation	of	caspase-8	allows	cleavage	
of	receptor	 interacting	kinase	1	(RIPK1)	and	through	a	negative	 feedback	 inhibits	necroptosis	






ideal	 for	 an	 intracellular	 pathogen,	 as	 it	 removes	 a	 niche	 for	 replication,	 however	 ‘delayed	
apoptosis’	as	 a	 result	 has	been	 linked	 to	disease	 (Kennedy	and	Deleo,	 2009).	 Pathogens	have	
evolved	mechanisms	 to	 inhibit	 host	 cell	 apoptosis,	 thus,	 alternative	 death	 pathways	 (such	 as	
inflammatory)	must	be	executable	by	the	immune	system.	
1.4.5.2 Efferocytosis	





surface	 (Bratton	 and	 Henson,	 2011,	 Poon	 et	 al.,	 2014).	 ‘Find-me’	 signals	 are	 immune	 cell	
chemoattractants,	while	 ‘Eat-me’	 and	 ‘Don’t	 eat-me’	 signals	 respectively	 increase	or	 suppress	
macrophage	 receptor	 recognition	 (Bratton	 and	 Henson,	 2011).	 The	 release	 of	 adenosine	
triphosphate,	uridine	triphosphate	and	other	DAMPs	can	act	as	non-selective	 ‘Find-me’	signals	
for	further	recruitment	of	immune	cells	(Chekeni	and	Ravichandran,	2011,	Ravichandran,	2010).	








et	 al.,	 2009).	 The	 removal	 of	 apoptotic	 cells	 via	 efferocytosis	 promotes	 the	 release	 of	 anti-





clear	 dying	 cells	 can	 result	 in	 secondary	 necrosis	 of	 apoptotic	 bodies,	 cellular	 crowding	 and	
release	 of	 inflammatory	 products	 into	 the	 surrounding	 tissue,	 potentially	 contributing	 to	
pathogenicity	 (Silva,	 2010).	 Although	 predominantly	 considered	 a	 post-apoptotic	 response,	








Germic	 et	 al.,	 2019,	 Kim	 et	 al.,	 2019).	 Autophagy	 emerges	 as	 an	 important	 mechanism	 of	
neutrophil-mediated	 pathogen	 defence	 as	 recent	 reviews	 summarise	 roles	 in	 phagocytosis,	
degranulation,	 ROS	 production,	 cytokine	 release	 (IL-1β)	 and	 cell	 death	 (Germic	 et	 al.,	 2019).	
Autophagy	 can	 be	 summarised	 as	 occurring	 in	 five	 mechanistic	 steps:	 initiation,	 elongation,	










Figure	1.3:	Anti-inflammatory	mechanisms	of	 cell	 death.	Extrinsic	 apoptosis	 occurs	 following	 FAS-
ligand	 (FASL),	 tumour	 necrosis	 factor	 (TNF)-α	 receptor	 and	 TNF-related	 apoptosis-inducing	 ligand	
(TRAIL)	binding,	which	results	in	activation	of	caspase	(CSP)-8.	Reactive	oxygen	species	(ROS)	production	
or	cellular	stress	can	initiate	intrinsic	apoptosis,	causing	caspase-8	activation	or	release	of	cytochrome	c	
(Cyt	 c)	 from	 the	 mitochondria	 (MT)	 and	 caspase-9	 activation,	 respectively.	 Autophagy	 is	 a	 five-step	
intracellular	 process	 that	 degrades	 pathogens	 via	 fusion	 with	 lysosomes.	 Following	 the	 induction	 of	
apoptosis,	 cells	 release	 “find	 me”	 signals	 (including	 phosphatidylserine	 (PS)	 “flipping”,	 adenine	
triphosphate	 (ATP)	 and	uridine	 triphosphate	 (UTP)	 release)	 and	 lose	 “don’t	 eat	me”	 signals,	 initiating	
clearance	 of	 debris	 by	 macrophages	 via	 efferocytosis.	 Anti-inflammatory	 cytokines	 are	 released	 by	















all	 inflammatory	death	pathways	described	 in	neutrophils	 that	can	be	distinguished	 from	one	
another	due	to	their	unique	components	that	coordinate	the	outcome	(Figure	1.4).	The	induction	







Kanneganti,	 2016).	 Pyroptotic	 death	 amplifies	 the	 inflammatory	 response	 through	 release	 of	
DAMPs	and	downstream	events	(LaRock	and	Cookson,	2013).	Pyroptosis	has	been	identified	in	
neutrophils	responding	to	bacterial	infection	(Ryu	et	al.,	2017),	however	most	research	advances	
in	understanding	pyroptosis	and	 inflammasomes	have	 focused	on	macrophages.	 Initiation	can	
occur	 through	 canonical	 (caspase-1-dependent)	 and	 non-canonical	 (caspase-1-independent)	
pathways,	 both	 triggering	 the	 cleavage	of	GSDMD	and	 culminating	 in	 cell	pore	 formation	 and	




and	 caspase-1	 (Man	 and	 Kanneganti,	 2015,	 Man	 and	 Kanneganti,	 2016).	 The	 inflammasome	
activates	 the	 bound	 caspase-1	 and	 can	 further	 cleave	 and	 activate	 GSDMD,	 IL-1β	 and	 IL-18.	









which	 in	 turn	 results	 in	 activation	 of	 caspase-1	 and	 then	 IL-1β	and	 IL-18	 (Man	 et	 al.,	 2017).	
Though	 inflammasomes	 are	 essential	 to	 pyroptosis,	 it	 is	 believed	 that	 the	 formation	 of	 an	
inflammasome	does	not	automatically	lead	to	cell	death	(Chen	et	al.,	2020).	
Pyroptosis	is	an	alternative	method	of	cell	death-mediated	host	immunity,	as	cell	lysis	promotes	
the	 further	 recruitment	of	 immune	 cells,	 and	also	deprives	 the	pathogens	of	 the	 intracellular	
environment	 (LaRock	 and	 Nizet,	 2015).	 Following	 lysis,	 pathogens	 then	 confront	 increased	
numbers	 of	 primed	 immune	 cells	 that	 are	 assumed	 to	 be	more	 effective	 (Miao	 et	 al.,	 2010).	
Through	the	use	of	caspase-knockout	mice,	the	induction	of	pyroptosis	has	been	demonstrated	
to	be	beneficial	during	both	gram-positive	and	gram-negative	infections	in	vivo,	though	this	has	
not	 been	 shown	 for	 GAS	 infection	 specifically	 (Man	 et	 al.,	 2017).	 Pyroptosis	 has	 been	
demonstrated	 in	macrophages	 in	 response	 to	GAS	 infection	(Valderrama	et	 al.,	 2017).	During	
macrophage	pyroptosis	the	formation	of	pore-induced	intracellular	traps,	similar	to	that	of	NETs,	
has	been	reported	to	occur	for	Salmonella	enterica	serovar	Typhimurium	(Jorgensen	et	al.,	2016).	
Pore-induced	 intracellular	 traps	 limit	 the	 escape	 of	 intracellular	 bacteria	 during	 pyroptotic	
macrophage	lysis	and	assist	neutrophils	during	their	clean-up	role	in	efferocytosis	(Jorgensen	et	





been	demonstrated	 for	other	 invasive	pathogens	such	as	Pseudomonas	aeruginosa	 (Ryu	et	al.,	





investigating	 pyroptosis	 in	 leukocytes	 have	 since	 been	 proposed	 (Tran	 et	 al.,	 2019),	 though	
characterisation	of	neutrophils	during	GAS	infection	trials	behind	other	pathogens.	
1.4.6.2 NETosis	
Neutrophils	 can	 release	NETs	 in	 response	 to	 pathogens	 (Brinkmann	 et	 al.,	 2004),	 during	 the	
inflammatory	 process	 referred	 to	 as	NETosis.	 During	NETosis,	 neutrophils	 expel	 intracellular	
chromatin	and	histones	(which	form	NETs),	along	with	granular	proteins	(such	as	MPO	and	LL-
37)	 and	DAMPs,	 as	 a	 pro-inflammatory	method	 of	 trapping	 and	 killing	 extracellular	 bacteria	
(Brinkmann	 et	 al.,	 2004).	 NET	 formation	 can	 occur	 through	 lytic	 or	 non-lytic	 pathways	
(Castanheira	 and	 Kubes,	 2019).	 Lytic	 NET	 release	 is	 initiated	 by	 NADPH	 oxidase	 activation,	




response	 to	 intracellular	 gram-negative	 pathogens	 has	 been	 demonstrated,	 establishing	 a	














Figure	 1.4:	 Inflammatory	mechanisms	 of	 neutrophil	 cell	 death.	Canonical	 pyroptosis	 involves	 the	
formation	of	a	NOD,	leucine	rich	repeat	and	pyrin	domain	protein	(NLRP),	NOD,	leucine	rich	repeat	and	
CARD	 domain	 protein	 (NLRC),	 absent	 in	 melanoma	 (AIM)2	 or	 pyrin	 inflammasome,	 which	 activates	
caspase	(CSP)-1.	Caspase-1	cleaves	gasdermin	D	(GSDMD),	forming	pores,	and	promotes	the	maturity	and	
release	of	 interleukin	 (IL)-1β	and	IL-18.	Non-canonical	activation	directly	activates	caspase-4/-5	which	
cleaves	 GSDMD.	 Necroptosis	 occurs	 during	 caspase-8	 inactivation	 following	 FAS-ligand	 (FASL),	 TNF-α	
receptor	(TNFR)	and	TNF-related	apoptosis-inducing	ligand	(TRAIL)	binding.	Receptor-interacting	protein	
kinase	(RIPK)1	then	binds	with	RIPK3	(necrosome)	and	both	become	phosphorylated	(P).	Mixed	lineage	













Necroptosis	 is	 a	 pro-inflammatory	 caspase-independent	 death	 pathway,	 where	 significant	
developments	in	understanding	necroptosis	have	been	made	over	the	past	decade	(Berghe	et	al.,	
2014,	 Tait	 et	 al.,	 2014).	 Induction	 of	 necroptosis	 occurs	 when	 caspase	 activation	 fails	 and	
safeguards	against	pathogens	that	may	be	trying	to	use	the	cell	for	immune	evasion	or	replication.	
Activation	of	necroptosis	in	neutrophils	can	occur	following	TNF-⍺	receptor	binding,	TLR	binding,	
the	 detection	 of	 intracellular	 pathogen	 DNA	 or	 ribonucleic	 acid	 (RNA)	 and	 treatment	 with	




another	 through	 receptor	 interacting	 protein	 homotypic	 interaction	 motif	 domains.	 The	
RIPK1/RIPK3	 complex	 joins	 with	 FADD	 and	 caspase-8	 to	 form	 the	 necrosome	 and	 becomes	
phosphorylated	(Vandenabeele	et	al.,	2010).	Mixed-lineage	kinase	domain-like	protein	(MLKL)	
associates	 to	 the	 RIPK3	 portion	 of	 the	 necrosome.	 MLKL	 becomes	 phosphorylated	 (pMLKL)	
(Barbosa	et	al.,	2018)	and	phosphorylation	 initiates	oligomerisation	of	pMLKL	molecules	as	a	
four-helix	 bundle	 (Murphy	 et	 al.,	 2013,	 Orozco	 et	 al.,	 2014,	Wu	 et	 al.,	 2014).	 Insertion	 of	 the	
pMLKL	oligomers	into	the	plasma	membrane	subsequently	forms	pores	(Weber	et	al.,	2018).	The	





are	 phenotypic	 characteristics	 of	 necroptosis	 (Malanski	 et	 al.,	 2003),	 where	 lysis	 promotes	
inflammation	 via	 the	 release	 of	 DAMPs	 and	 granular	 molecules	 (Kaczmarek	 et	 al.,	 2013,	
Pasparakis	and	Vandenabeele,	2015).	DAMPs	commonly	released	during	necroptosis	include	high	





2000).	The	 induction	of	necroptosis	has	been	demonstrated	 in	human	neutrophils	 (Greenlee-
Wacker	 et	 al.,	 2017)	 and	murine	 immune	 cells	 (Kitur	 et	 al.,	 2016)	 in	 response	 to	 S.	 aureus,	
although	these	reports	conflict	on	whether	necroptosis	aids	or	hinders	the	resolution	of	infection.	
The	role	of	neutrophil	necroptosis	in	GAS	disease	however,	remains	unclear	and	requires	further	
investigation.	 The	 overlap	 of	 molecules	 from	 both	 anti-inflammatory	 and	 proinflammatory	
pathways	further	indicates	that	all	cell	death	is	a	complex	and	dynamic	mechanistic	process.	
1.5 Development	of	invasive	GAS	infection	








been	 shown	 to	 contribute	 to	 the	 development	 of	 invasive	 disease	 (Reglinski	 and	 Sriskandan,	
2014,	Walker	et	al.,	2014).	The	host	immune	response	to	GAS	however,	is	less	well-characterised,	
particularly	for	neutrophils,	even	though	disruption	to	homeostatic	immune	responses	impact	
the	 progression	 of	 invasive	 GAS	 disease	 (Lawrence	 et	 al.,	 2018,	 Lawrence	 et	 al.,	 2020).	 The	
hyperinflammation	 seen	 during	 invasive	 GAS	 infections,	 may	 be	 a	 product	 of	 both	 bacterial	
virulence	 factors	 expression	 such	 as	 toxins,	 but	 also	 disruption	 caused	 to	 the	 hosts	 immune	
system.	A	new	perspective	for	invasive	GAS	infection	that	incorporates	both	host	and	bacterial	







Genetic	 differences	 between	 hosts	 also	may	 play	 a	 role	 in	 the	 development	 and	 outcomes	 of	
invasive	 GAS	 infection.	 Individuals	 can	 have	 reduced	 susceptibility	 to	 severe	 systemic	 GAS	











common	 for	 infection	 studies,	 this	 evidence	 highlights	 that	 caution	 should	 be	 taken	 when	















only	 between	 GAS	 strains	 associated	 with	 different	 disease	 states	 but	 also	 after	 “genetic	
switching”	during	an	 infection	(Fiebig	et	al.,	2015,	Hollands	et	al.,	2010,	Kilsgård	et	al.,	2016).	
Higher	expression	of	virulence	factors	associated	with	immune	evasion	are	evident	in	strains	that	
have	 undergone	 genetic	 switching	 (Kilsgård	 et	 al.,	 2016).	 GAS	 virulence	 factors	 that	 bestow	




by	 host	 immune	 cells,	 as	 it	 is	 structurally	 identical	 to	 HA	 found	 in	 human	 connective	 tissue	
(Cunningham,	 2000).	 GAS	 HA	 limits	 the	 surface	 binding	 of	 antibodies	 and	 interferes	 with	
complement	deposition,	 providing	 increased	protection	 from	opsonophagocytosis	 (Dale	 et	 al.,	






of	 M	 protein	 to	 host	 factors	 fibrinogen,	 factor	 H	 and	 plasminogen	 (Courtney	 et	 al.,	 2006,	









Virulence	factor	 Gene	 Area	of	immunity	 Mechanism	 References	
Hyaluronic	acid	capsule		 hasA	 Opsonisation	 Molecular	mimicry	to	extracellular	matrix	avoids	opsonisation	 (Cunningham,	2000)	
(HA)	 	 	 Blocks	antibody	access	to	surface	 (Dinkla	et	al.,	2007)	
	 	 	 Inhibits	complement	deposition	 (Dale	et	al.,	1996)	
	 	 	 Resistance	to	opsonophagocytosis	 (Dale	et	al.,	1996,	Foley	and	Wood	Jr,	1959)	
	 	 Neutrophil	killing	 Enhances	survival	within	NETs	 (Cole	et	al.,	2010)	
M-protein	and	M-like		 mga	 Opsonisation	 Fibrinogen	binding	blocks	C3	convertase	cell-surface	deposition	 (Courtney	et	al.,	2006)	
proteins	 	 	 Plasminogen	binding	prevents	C3b	opsonisation	 (Ly	et	al.,	2014)	
	 	 	 Binds	factor	H	accelerating	C3b	degradation	 (Horstmann	et	al.,	1988)	
	 	 Phagocytosis	 Bind	IgA	and	IgG	at	the	Fc	regions,	inactivating	 (Fagan	et	al.,	2001)	
	 	 Oxidative	burst	 Impairs	phagosome	maturation	when	internalised	 (Staali	et	al.,	2006)	
	 	 AMP	resistance	 Working	in	conjunction	with	HA	provides	resistance	to	LL-37	 (Cole	et	al.,	2010)	
	 	 Cellular	invasion	 Inactivates	complement	C4b	through	protein	H,	and	increases	epithelial	invasion	 (Ermert	et	al.,	2013)	
Streptolysin	S	(SLS)	 sag(A-I)	 Phagocytosis	 Disrupts	neutrophil	phagocytosis	by	forming	hydrophilic	pores	in	membranes	 (Datta	et	al.,	2005,	Miyoshi-Akiyama	et	al.,	2005)	
	 	 Inflammation	 Host	cell	lysis	of	lymphocytes,	erythrocytes,	macrophages	and	platelets	 (Goldmann	et	al.,	2009,	Ofek	et	al.,	1970)	
Streptolysin	O	(SLO)	 slo	 Inflammation	 Release	of	cytotoxic	inflammatory	molecules	from	neutrophils	 (Nilsson	et	al.,	2006)	
	 	 	 Disrupts	host	neutrophil,	macrophage	and	epithelial	membranes	 (Bricker	et	al.,	2002,	Goldmann	et	al.,	2009,	Timmer	et	al.,	2009)	
	 	 Phagocytosis	 Resistance	to	endosomal	and	lysosomal	formation	 (Håkansson	et	al.,	2005)	
	 	 Cytotoxicity	 Allows	translocation	of	NADase	into	host	cells	 (Karasawa	et	al.,	1995,	Madden	et	al.,	2001,	Stevens	et	al.,	2000)	
	 	 Tissue	damage	 Facilitates	SpeA	penetration	of	cells,	resulting	in	inflammation	and	tissue	damage	 (Brosnahan	et	al.,	2009)	
	 	 Phagocytosis	 Disrupts	clathrin-dependent	pathways	of	internalisation	 (Logsdon	et	al.,	2011)	
Streptococcal	inhibitor	of		 sic	 Opsonisation	 Binds	and	inhibits	complement	C5b67	 (Åkessont	et	al.,	1996,	Fernie-King	et	al.,	2001)	
complement-mediated		 	 AMP	resistance	 Inactivates	leukocyte	protease	inhibitor,	lysozyme,	human	α-defensin-1	and	LL-37	 (Fernie-King	et	al.,	2002,	Fernie-King	et	al.,	2004,	Frick	et	al.,	2003)	
lysis	 	 Adherence	 Increase	epithelial	cell	adherence	and	mucosal	colonisation	 (Hoe	et	al.,	2002,	Lukomski	et	al.,	2000)	
IgG-degrading	enzyme	of	 mac	 Opsonisation	 Degrades	IgG	at	Fc	region	and	CD11b,	inhibiting	opsonophagocytosis	 (Åkesson	et	al.,	2006,	Lei	et	al.,	2001,	Von	Pawel-Rammingen	et	al.,	2002)	
Streptococcus	pyogenes	 	 Oxidative	Burst	 Inhibit	neutrophil	activation	and	ROS	production	via	CD16	binding	 (Kawabata	et	al.,	2002,	Lei	et	al.,	2001)	
Streptococcal	pyogenic		 speA	 Inflammation	 Activation	of	host	immune	cells	and	resulting	cytokine	release	 (Norrby-Teglund	and	Johansson,	2013)	
exotoxin	A	(SpeA)	 	 	 Binds	human	leukocyte	antigen	class	II	invoking	cytokine	release	 (Kotb	et	al.,	2002)	
Streptococcal	pyogenic		 speB	 Dissemination	 Degrades	host	extracellular	matrix	components	via	protease	activity	 (Kapur	et	al.,	1993a;	Burns	et	al.,	1996)	
exotoxin	B	(SpeB)	 	 Opsonisation	 Degrades	IgG,	IgA,	IgM,	IgD	and	IgE	 (Schmidtchen	et	al.,	2002)	
	 	 AMP	resistance	 Inactivates	and	cleaves	antimicrobial	peptide	LL-37	 (Schmidtchen	et	al.,	2002)	
	 	 	 Release	of	dermatan	sulphate	 (Schmidtchen	et	al.,	2001)	
Streptococcal	C5a		 scpA	 Phagocytosis	 Cleaves	C5a	 (Chen	and	Cleary,	1990,	O'Connor	and	Cleary,	1986)	
peptidase	 	 Chemotaxis	 Cleaves	C5a	binding	site	on	neutrophil	cell-surface	 (Demaster	et	al.,	2002)	
S.	pyogenes	cell	envelope		 spyCEP	 Chemotaxis	 Degrades	neutrophil	attractant	IL-8	by	cleavage	 (Edwards	et	al.,	2005,	Zinkernagel	et	al.,	2008)	
protease	(SpyCEP)	 	 	 Post-transcriptionally	dampens	epithelial	IL-8	release	 (Soderholm	et	al.,	2018)	
Streptococcus	ADP-ribosyl	
transferase	
spyA	 Inflammation	 Invokes	IL-1β	release	 (Lin	et	al.,	2015)	
Streptodornase	1	(Sda1)	 sda1	 NETs	 Degrade	NETs	with	DNase	activity	 (Buchanan	et	al.,	2006,	Walker	et	al.,	2007)	
	 	 Inflammation	 Reduces	macrophage	release	of	IFN-α	and	TNF-α	 (Uchiyama	et	al.,	2012)	
	 	 Activation	 Reduces	TLR9	recognition	of	pathogen-associated	molecular	patterns	 (Uchiyama	et	al.,	2012)	
Cell-wall	anchored	nuclease	A	 spnA	 NETs	 Degradation	of	NETs	through	nuclease	activity	 (Chang	et	al.,	2011)	
Streptokinase	 ska	 Dissemination	 Activates	host	protein	plasminogen	which	degrades	host	extracellular	matrix	 (Sun	et	al.,	2004)	
NAD-glycohydrolase	 nga	 Cytotoxicity	 Production	of	cyclic	adenosine	diphosphate-ribose	 (Madden	et	al.,	2001,	Stevens	et	al.,	2000)	
	 	 Chemotaxis	 Inhibited	directed	migration	due	to	limited	activation	 (Stevens	et	al.,	2000)	







by	 GAS,	 contributing	 to	 β-haemolysis.	 SLO	 oligomerises	 and	 disrupts	 host	 cell	 membranes	
including	 erythrocytes,	 neutrophils,	macrophages,	 platelets	 and	 epithelial	 cells	 (Bhakdi	 et	 al.,	
1985,	Bricker	et	al.,	2002,	Goldmann	et	al.,	2009,	Limbago	et	al.,	2000,	Sierig	et	al.,	2003,	Timmer	
et	al.,	2009).	Rupture	of	neutrophil	membranes	releases	cytotoxic	molecules	which	can	also	act	
to	 promote	 inflammation	 (Nilsson	 et	 al.,	 2006).	 Intracellular	 secretion	 of	 SLO	 facilitates	







SLS,	which	 can	 then	 continue	 to	 have	 cytotoxic	 effects	 upon	 the	 cell	 (Miyoshi-Akiyama	 et	 al.,	
2005).	 Evidence	 suggests	 that	 SLS-mediated	 lysis	 contributes	 to	 GAS	pathogenesis,	 inhibiting	




2003).	 In	 another	mouse	model	 of	 invasive	 GAS	 infection,	 when	 slo	 and	 sagA	 are	 abrogated	
together,	lesion	size	and	bacterial	load	are	significantly	reduced	(Goldmann	et	al.,	2009).	SLS	also	













bacterial	 dissemination	 (Burns	 Jr	 et	 al.,	 1996,	 Kapur	 et	 al.,	 1993).	 SpeB	 also	 degrades	









(Zinkernagel	 et	 al.,	 2008).	 GAS	 isolated	 from	 blood	 or	 invasive	 infection	 show	 increased	
degradation	of	IL-8,	therefore	suggesting	a	role	for	SpyCEP	in	the	development	of	invasive	disease	
(Edwards	 et	 al.,	 2005).	 Complement	 is	 another	 important	 host	 factor	 that	 assists	 with	


















Regardless	 of	 which	 of	 the	 above	 virulence	 factors	 are	 involved,	 bacteria	 that	 bypass	 host	
immunity	have	an	increased	likelihood	of	causing	invasive	infections.	Thus,	a	large	portion	of	GAS	
host-pathogen	 research	 has	 focused	 upon	 virulence	 factors	 to	 date.	 A	 discussion	 of	 all	 GAS	
virulence	 factors	 is	 beyond	 the	 scope	 of	 this	 review,	 however	 further	 reading	 of	 other	
comprehensive	 reviews	 can	 provide	 additional	 information	 (Reglinski	 and	 Sriskandan,	 2014,	
Walker	et	al.,	2014).	
1.5.3 CovRS	and	M1T1	propensity	to	cause	invasive	infection	
GAS	 virulence	 factor	 regulation	 is	 influenced	 by	 the	 environment	 but	 also	 controlled	 by	




Under	 normal	 conditions,	 CovS	 is	 able	 to	 bind	 CovR	 and	 control	 the	metabolically	 expensive	
production	of	virulence	factors	involved	in	innate	immune	resistance	and	tissue	destruction	such	
as;	 streptokinase,	 SLO,	 HA,	 SLS,	 SpeA,	 cell	 wall-anchored	 nuclease	 A,	 Sda1,	 immunoglobulin-
degrading	enzyme	S,	 streptococcal	 inhibitor	of	complement	and	SpyCEP	(Graham	et	al.,	2002,	
Sumby	et	al.,	2006,	Treviño	et	al.,	2009).	Mutations	to	the	covRS	disrupt	either	the	gene	for	the	








occurs,	 reducing	 the	 degradation	 of	 bacterial	 cell-surface	 proteins	 and	 allowing	 increased	
interactions	with	host	blood	components	(Maamary	et	al.,	2010).	
Increased	 GAS	 resistance	 to	 phagocytosis	 and	 neutrophil	 killing	 (Sumby	 et	 al.,	 2006)	 further	
confers	hypervirulence	in	mouse	models	of	systemic	infection	(Engleberg	et	al.,	2001,	Walker	et	
al.,	2007).	Although	strains	 isolated	 from	invasive	 infection	commonly	have	covR/S	mutations	
(Maamary	et	al.,	2010),	it	is	not	essential	in	order	to	cause	invasive	disease	(Davies	et	al.,	2019).	
Studies	have	shown	that	M1T1	GAS	have	a	higher	propensity	for	covR/covS	mutation	and	may	be	
in	part	a	 reason	 for	 its	 frequent	 identification	 in	 invasive	disease	 (Aziz	 et	al.,	 2004).	 “Genetic	
switching”	of	M1T1	is	thought	to	occur	following	colonisation,	which	sees	the	selective	rise	of	






strains	are	 able	 to	 avoid	 clearance	by	 apoptotic	 immune	 cells,	 redirecting	 immune	 cell	 death	
through	an	 inflammatory	mediated	pathway	(Goldmann	et	al.,	2009,	Tsatsaronis	et	al.,	2015).	
However,	 limited	 studies	 have	 focused	 on	 the	 interplay	 between	 immune	 cell	 resistance,	
inflammatory	 responses	 and	 immune	 cell	 death.	 Two	 well-characterised	 covS	 GAS	 mutants	
5448AP	(M1T1,	containing	a	mutation	obtained	following	animal	passage)	(Aziz	et	al.,	2004)	and	
NS88.2	 (M98.1,naturally	 occurring	mutation	 acquired	 during	 clinical	 infection)	 (McKay	 et	 al.,	
2004)	 both	 display	 a	 single	 change	 in	 nucleotide	 sequence	 of	 covS	 (Figure	1.5).	 The	 result	 is	
increased	bacterial	 resistance	 to	neutrophil	killing	and	 increased	propensity	 to	cause	 invasive	
disease	in	mouse	models	of	GAS	infection	(Maamary	et	al.,	2010).	As	such,	these	strains	may	serve	
as	 models	 for	 studying	 the	 immune	 response	 during	 invasive	 GAS	 infection,	 allowing	 better	






Figure	 1.5:	 Mutations	 to	 the	 control	 of	 virulence	 regulator	 system	 influence	 the	 regulation	 of	











migration,	 oxidative	burst,	 bacterial	 killing	 and	 cytokine	 release	have	 all	 been	 reported	 to	be	
affected	(Hotchkiss	et	al.,	2013).	A	previous	review	has	outlined	the	role	that	GAS	superantigens,	
M1-mediated	 heparin	 binding	 release	 and	 SLO	 play	 in	 contributing	 to	 excessive	 host	
inflammation	and	invasive	disease	(Tsatsaronis	et	al.,	2014).	Bacterial	modulation	of	neutrophil	
death	is	another	mechanism	that	can	contribute	to	the	development	of	invasive	infection.	Two	
reports	 have	 identified	 that	 GAS	 isolated	 from	 invasive	 infection	 can	 accelerate	 neutrophil	
apoptosis,	then	cause	secondary	necrosis	(Kobayashi	et	al.,	2003a),	and	 induce	a	lytic	 form	of	
neutrophil	 death	 (Tsatsaronis	 et	 al.,	 2015).	Though	 it	 has	been	mentioned	 that	 inflammatory	
death	pathways	may	 be	 an	 alternative	mechanism	 of	 host	 defence	 (Chapter	1.4.6),	 increased	






of	 neutrophils	 during	 GAS	 infection.	 Further	 research	 is	 needed	 to	 determine	 if	 GAS	 induce	
specific	inflammatory	death	pathways	in	neutrophils,	and	if	so,	 is	this	common	among	isolates	
from	 invasive	disease.	Host	cells	have	also	been	shown	to	act	as	a	reservoir	 for	GAS	survival.	
Though	 neutrophils	 normally	 initiate	 a	 hostile	 internal	 environment	 for	 phagocytosed	 GAS,	









should	 increase	 immediately,	 yet	 reduce	 after	 24	 h	 (Bratton	 and	 Henson,	 2011).	 Sustained	
increase	 in	 neutrophil	 population	 and	 overstimulation	 of	 inflammatory	 reactions	 can	 be	
detrimental	 to	 the	 host	 and	 counteract	 defensive	mechanisms,	 where	 GAS	 infection	 severity	
correlates	with	the	increased	amounts	of	inflammatory	mediators	(Johansson	et	al.,	2010,	Kotb	
et	 al.,	 2002,	Norrby-Teglund	et	al.,	 2000).	The	 ability	 of	GAS	to	 cause	 toxic	 shock	 is	 one	 such	
example	of	deregulation	of	inflammatory	processes	(Lappin	and	Ferguson,	2009,	Norrby-Teglund	
and	 Johansson,	 2013).	 A	 theoretical	 model	 outlines	 the	 homeostatic	 balance	 between	
inflammatory	and	anti-inflammatory	neutrophil	death	pathways	during	infection	control	(Figure	
1.6),	where	disruption	 to	 either	 side	 could	promote	 conditions	 favouring	 the	development	of	
invasive	disease	(Lawrence	et	al.,	2020).	Hence,	the	mode	by	which	neutrophils	die	during	GAS	
infection	may	make	a	significant	contribution	to	the	development	of	invasive	disease.	If	there	is	



















































Item	 Volume/size	 Product	code/s	 Supplier	1	
Flow	cytometry	tubes	 5	mL	 55.1579	 Sarstedt	
Tube	 1.5	mL	 616201	 Griener	Bio-One		
Tube	 2	mL	 0030120.094	 Eppendorf	






Inoculation	loops	 10	µL	 86.162.010	 Sarstedt	






















Plate	flat-bottom	 96-well	 655101	 Greiner	Bio-One	
Plate	v-bottom	 96-well	 651101	 Greiner	Bio-One	








































Bsp68I,	within	 the	multiple	 cloning	 site	 (GenScript,	 Piscataway,	NJ,	USA),	 resulting	 in	pUC57-
RBSGFP	(Figure	2.1).	The	following	plasmid	construction	was	performed	by	Heema	K.	N.	Vyas	
and	Jason	D.	McArthur.	RBS	and	gfp	from	pUC57-RBSGFP	were	sub-cloned	using	NotI	(Fermentas,	
Burlington,	 Canada)	 into	 the	 toxin–antitoxin	 (TA)	 stabilized	 expression	 plasmid	 pLZ12Km2-
P23R:TA,	 kindly	provided	by	Associate	Professor	Thomas	Proft	 (University	of	Auckland,	New	
Zealand)	 (Loh	 and	 Proft,	 2013),	 to	 produce	 pLZ12Km2-P23R-TA:GFP.	 The	 resultant	 plasmid	





































































P23R:TA	 plasmid	was	 digested	with	 20	U	NotI	 enzyme	 and	 further	 treated	with	 5	 U	 shrimp	
alkaline	phosphatase	(Fermentas).	The	pUC57-RBSGFP	plasmid	was	incubated	with	20	U	NotI	to	
excise	 the	 RBS	 and	 gfp	 gene	 from	 pUC57-RBSGFP,	 which	 were	 then	 ligated	 into	 digested	




E.	 coli	 strain	 MC1061	 pLZ12Km2-P23R-TA:GFP	 was	 grown	 overnight	 at	 37°C	 on	 LB	 agar	
containing	 200	 ug/mL	 kanamycin	 (Km200,	 kanamycin	 sulphate,	 Sigma-Aldrich).	 The	
manufacturer’s	instructions	for	the	Wizard	Plus	SV	Mini-prep	DNA	purification	system	(Promega,	
Madison,	WI,	USA)	were	followed	for	plasmid	purification	and	instructions	are	outlined.	Using	an	
inoculation	 loop,	 E.	 coli	 were	 scraped	 from	 the	 plate	 and	 resuspended	 in	 250	 μL	 of	 cell	




added,	 inverted	 four	 times	and	then	 centrifuged	(20,000	x	g	 for	10	min).	Clarified	 lysate	was	
transferred	carefully	to	a	new	spin	column	and	centrifuged	(20,000	x	g	for	1	min),	discarding	the	
flow	through.	To	the	column	750	μL	of	cell	wash	solution	was	added	and	centrifuged	(20,000	x	g	












































by	 centrifugation	 with	 a	 swing	 bucket	 rotor	 (350	 x	 g	 at	 RT	 for	 10	min).	 Erythrocytes	 were	
hypotonically	lysed	by	resuspending	the	pellet	with	5	mL	of	sterile	deionised	water	(Milli-Q	Q-
POD,	Millipore,	Burlington,	MA,	USA)	 and	 rotating	 the	 tube	 for	no	more	 than	30	 sec.	 Isotonic	
concentration	was	 restored	by	adding	HBSS	 to	50	mL.	Hypotonic	 lysis	was	 repeated.	Prior	 to	






for	10	min	and	 supernatant	 kept.	Neutrophils	were	diluted	 in	 complete	medium	 (RPMI-1640	
medium	containing	2%	(v/v)	heat-inactivated	autologous	plasma	and	2	mM	L-glutamine	(Life	
Technologies))	 to	 the	 desired	 concentration	 unless	 otherwise	 stated.	 Neutrophil	 purity	 was	
assessed	using	an	LSR	Fortessa	X-20	flow	cytometer	(BD)	via	distinct	forward	scatter-area	(FSC-










Purified	 human	 neutrophils	 were	 seeded	 into	 6-well	 plates	 and	 incubated	 at	 37°C	 and		
5%	CO2	as	indicated.	Each	well	was	gently	aspirated	into	a	separate	15	mL	tube.	Remaining	cells	
were	washed	from	the	well	with	cold	PBS	with	inhibitors	(PBSI,	1	x	PBS,	2	x	cOmplete	protease	




supernatant	 removed.	 Carefully,	 the	 cells	 were	 resuspended	 in	 2	 mL	 of	 cold	 PBSI	 and	
centrifugation	 repeated.	 Neutrophils	 were	 lysed	 with	 200	 µL	 of	 a	 modified	
radioimmunoprecipitation	assay	(RIPA)	buffer	(RIPA	2,	150	mM	NaCl	(Univar	Solutions,	Downers	
Grove,	 IL,	USA),	 5	mM	ethylenediaminetetraacetic	 acid	(EDTA,	Univar	 Solutions),	 50	mM	Tris	
(Astral	Scientific),	1.0%	(v/v)	Triton	X-100	(Sigma-Aldrich),	0.1%	(w/v)	Sodium	dodecyl	sulphate	
(SDS,	 Sigma-Aldrich),	 0.5%	 (w/v)	 sodium	 deoxycholate	 (DOC,	 Sigma-Aldrich),	 2	 x	 cOmplete	
protease	inhibitor	cocktail,	1	mM	phenylmethylsulphonyl	fluoride,	10	mM	sodium	fluoride,	10	
mM	 sodium	 pyrophosphate,	 10	 mM	 sodium	 molybdate	 and	 10	 mM	 β-glycerophosphate)	 by	
incubation	on	ice	for	30	min,	with	intermittent	vortexing.	The	soluble	fraction	was	separated	via	
centrifugation	 (20,000	 x	g	at	 4°C	 for	 20	min),	 and	 the	majority	 (180	 uL)	 of	 supernatant	was	
transferred	to	a	new	tube,	with	a	10	µL	aliquot	diluted	1:10	with	PBS	and	snap	frozen	in	liquid	N2	
for	 protein	 quantification.	 5	 x	 PAGE	 loading	 buffer	 (containing	 5%	 (v/v)	 2-mercaptoethanol,	
(Sigma-Aldrich),	Appendix	A)	was	added	to	the	clarified	lysate,	mixed,	and	then	heated	at	95°C	











a	new	well,	 then	25	μL	of	working	Reagent	A	was	 added	to	 each	well,	 followed	by	200	μL	of	
Reagent	B	to	each	well.	The	plate	was	gently	agitated	to	mix	and	left	at	RT,	protected	from	light,	















20	 min.	 Transfer	 was	 performed	 using	 the	 Mini	 Trans-Blot	 Module	 (Bio-Rad)	 in	 the	 Mini-













Following	 transfer,	 PVDF	membranes	were	 briefly	 washed	 in	 Tris-buffered	 saline	 containing	
0.1%	(v/v)	 tween	20	(TBST,	Appendix	A).	PVDF	membranes	were	blocked	 for	1	h	at	RT	with	
gentle	agitation	to	reduce	non-specific	antibody	binding,	using	BSA	or	skim	milk	powder	(SMP,	






10	 min,	 then	 twice	 for	 5	 min	 using	 gentle	 agitation.	 Antibody	 detection	 was	 performed	 via	
chemiluminescence	using	the	Clarity	or	Clarity	Max	Western	ECL	Blotting	Substrates	(Bio-Rad)	











Antibody	 Company	 Product	#	/Clone	 Dilution	1	 Blocking	
buffer	
Primary	 	 	 	 	
Rabbit	anti-human	caspase-1	pAb	 CST	 2225/-	 1:2000	 5%	SMP	
Rabbit	anti-human	caspase-3	pAb	 CST	 9662/-	 1:2000	 5%	SMP	
Rabbit	anti-human	caspase-4	pAb	 CST	 4450/-	 1:1000	 5%	BSA	
Rabbit	anti-human	caspase-8	
mAb	
CST	 4790/D35G2	 1:1000	 5%	BSA	
Rabbit	anti-human	GSDMD	pAb	 Sigma-Aldrich	 G7422/-	 1:500	 5%	SMP	
Mouse	anti-human	β-actin	mAb	 CST	 3700/8H10D10	 1:1000	 5%	SMP	
Rabbit	anti-human	GAPDH	mAb	 Abcam	 ab181602/ERP16891	 1:10,000	 1%	BSA	
Secondary	 	 	 	 	
Goat	anti-mouse	IgG	HRP	pAb	 Abcam	 ab97023/-	 1:20,000	 5%	SMP	
Goat	anti-rabbit	IgG	HRP	pAb	 Invitrogen	 65-6120	 1:5000	 5%	SMP	
1	Dilution	dictates	antibody:	buffer	ratio.	 	 	 	 	 	 	 	 	
Abbreviations:	BSA,	bovine	serum	albumin;	CST,	Cell	Signalling	Technologies,	Danvers,	MA,	USA;	GSDMD,	























































For	 assays	 where	 downstream	 immunoblot	 analysis	 was	 required	 to	 investigate	 cell	 death	
markers,	human	neutrophils	were	seeded	into	flat-bottom	6-well	plates	(1.32	x	106	cells/well)	
and	infected	with	GAS	at	MOI	10:1.	Plates	were	incubated	at	37°C	in	5%	CO2	for	the	indicated	
times.	 Following	 incubation	 each	 well	 was	 gently	 aspirated	 into	 a	 separate	 15	mL	 tube	 and	
methods	were	performed	as	previously	outlined	(Chapter	2.4).	
2.7.6 Annexin-V/viability	staining	
To	 assess	 cell	 viability,	 human	 neutrophils	 were	 seeded	 into	 24-well	 plates		
(5	x	105	cells/well)	and	infected	with	GAS	at	MOI	10:1.	Plates	were	incubated	at	37°C	in	5%	CO2	
for	 the	 indicated	 times.	 Neutrophils	were	 removed	 and	washed	with	 annexin-V	 assay	 buffer	
(Appendix	A)	then	incubated	with	Zombie	Aqua	Fixable	Viability	Kit	(BioLegend)	for	15	min	at	
RT.	Cells	were	washed	again	once	with	annexin-V	assay	buffer,	then	once	more	with	10%	(v/v)	







37°C	in	5%	CO2	 for	 the	 indicated	times.	Caspase-1	activation	was	measured	using	FAM-FLICA	
Caspase-1	 assay	 kit	 (ImmunoChemistry	 Technologies,	 Bloomington,	 MN,	 USA)	 as	 per	 the	
manufacturer’s	recommendations.	Neutrophils,	in	the	absence	or	presence	of	GAS,	were	removed	













then	 snap	 frozen	 in	 liquid	 N2	 and	 stored	 at	 -80°C	 for	 a	 period	 no	 longer	 than	 5	 days.	 The	
LEGENDplex™	 13-plex	 human	 inflammation	 panel	 bead-based	 immunoassay	 (interleukin-1β,	
type	 I	 interferon-α2,	 type	 I	 interferon-γ,	 tumour	necrosis	 factor-α,	monocyte	 chemoattractant	





(PE)-conjugated	streptavidin	was	 then	added	and	 incubated	 for	 a	 further	30	min	 at	RT,	with	
shaking	 (600	 rpm)	 protected	 from	 light.	 Beads	were	washed	 twice	with	 LEGENDplex™	wash	
buffer	and	data	collected	using	an	LSR	Fortessa	X-20	flow	cytometer.	Beads	were	initially	gated	




















stained	 with	 fluorochrome-conjugated	 antibodies	 (Table	 2.3)	 according	 to	 titrated	 volumes	
(Appendix	F)	for	15	min	at	RT	protected	from	the	light.	Neutrophils	were	washed	with	10%	(v/v)	
FBS	in	PBS	then	analysed	using	an	LSR	Fortessa	X-20	flow	cytometer.	
Table	 2.4:	 Fluorochrome	 conjugated	 antibodies	 and	 fluorescent	 dyes	 used	 for	 human	 in	 vitro	
experiments	in	this	thesis.	
Antibody/Dye	 Company	 Product	#/Clone	 Volume	per	test	(μL)	
FITC	anti-human	CD11b	 BioLegend	 301330/ICRF44	 2	
FITC	anti-human	CD16	 BioLegend	 556618/3G8	 2	
PE/Cy7	anti-human	CD31	 BioLegend	 303118/WM59	 1	
PE	anti-human	CD47	 BioLegend	 323108/CC2C6	 2	
PE	anti-human	CD64	 BioLegend	 305008/10.1	 3	
PerCP/Cy5.5	anti-human	CD66b	 BioLegend	 305108/G10F5	 2	
PerCP/Cy5.5	anti-human	CD66b*	 BD	 562254/G10F5	 3	
Zombie	NIR	 BioLegend	 423105/-	 1	
Zombie	Aqua	 BioLegend	 423102/-	 1	
*	Antibody	was	not	titrated.	 	 	 	 	 	 	 	 	 	

















3 Optimisation	 of	 methods	 for	 isolation	 of	 intracellular	
proteins	in	human	neutrophils	
3.1 Introduction	





























antimicrobial	 activity,	 production	 of	 reactive	 oxygen	 species	 (ROS)	 and	 release	 of	 neutrophil	
extracellular	traps	(NETs)	 in	response	to	gram	positive	pathogen	Staphylococcus	aureus	when	
compared	to	primary	human	blood	neutrophils	 (Yaseen	et	al.,	2017).	HL-60	cells	lack	specific	
granules	 unlike	 neutrophils	 (Sheppard	 et	 al.,	 2005),	 which	 could	 reduce	 intraphagosomal	
oxidative	 activity.	 Similarly,	 with	 Streptococcus	 pyogenes	 (Group	 A	 Streptococcus,	 Group	 A	
Streptococci,	GAS),	bacterial	internalisation	and	killing	is	reduced	when	comparing	HL-60	cells	to	









Ignorance	 of	 these	 factors	 or	 treatment	 of	 neutrophils	 like	 immortalised	 cells	 can	 result	 in	
premature	activation,	decreasing	functional	capacity	and	causing	cell	coagulation.	Protocols	for	




immunoblot	 reproducibility	 and	 to	 allow	 comparison	 between	 experiments.	 Three	 common	




glyceraldehyde	 3-phospahte	 dehydrogenase	 (GAPDH).	 Normalisation	 accounts	 for	 small	
variations	that	may	occur	between	samples	or	lanes	and	allows	for	semi-quantitative	analysis	of	
immunoblot	data.	Housekeeping	proteins	are	selected	based	upon	their	constitutive	expression	
and	 must	 be	 unaffected	 by	 experimental	 conditions.	 If	 this	 method	 is	 to	 be	 used,	 a	 linear	
relationship	must	be	demonstrated	between	the	signal	 intensity	and	volume	 loaded	 for	every	
antigen,	considering	the	linear	range	of	this	relationship	can	be	limited	by	the	chosen	technique	





Cell	 death	 is	 often	 investigated	 through	 screening	 for	 the	 activation	 or	 cleavage	 of	 caspases	
(Shalini	et	al.,	2015).	Caspases	are	intracellular	proteolytic	enzymes,	best	known	for	their	ability	




during	 lysis	 there	 is	 a	 risk	 of	 caspase-cleavage	 or	 sample	 degradation.	 Published	methods	 to	
prevent	granular	sample	damage	use	a	pre-incubation	step	 in	 the	 toxic	substance	diisopropyl	
flurophosphate	(Quinn	et	al.,	2007),	which	subsequently	hinders	further	neutrophil	functionality.	
Therefore,	this	chapter	aims	to	optimise	a	neutrophil	lysis	protocol	that	maximises	detection	of	








Human	 neutrophil	 preparation	 from	 healthy	 donors,	 handling,	 incubations	 and	 protein	





USA)	 in	 lysis	 buffer	 on	 ice.	A	power	of	 30%	was	applied	 for	10	 s,	 followed	by	10	 s	 rest,	 and	
repeated	two	more	 times	 for	a	total	time	of	60	s.	 In	some	experiments,	 samples	were	quickly	
sheared	 three	 times	 through	a	25	G	needle	and	1	mL	syringe,	onto	 the	wall	of	a	1.5	mL	tube.	
Protein	concentration	was	determined	in	samples	as	previously	stated	(Chapter	2.6.2).	
3.2.3 Sodium	dodecyl	sulphate-polyacrylamide	gel	electrophoresis	






comparison	 to	 the	 Precision	 Plus	 Protein	 Dual	 Colour	 Standards	 (Bio-Rad).	 Samples	 were	
separated	by	applying	100	V	 for	10	min,	 followed	by	180	V	 for	50	min	using	a	PowerPac	300	
Supply	Unit	(Bio-Rad),	in	PAGE	running	buffer	(Appendix	A).	Protein	bands	were	visualised	by	
staining	 in	Coomassie	Brilliant	Blue	 rapid	 stain	(Appendix	A)	with	 gentle	agitation	overnight.	









Reagent	a	 NP-40	 RIPA	1	 RIPA	2	 RIPA	3	 PBSI	1	 PBSI	2	
Nonidet	P-40	(%)	 1.0	 -	 -	 -	 -	 -	
Triton	X-100	(%)	 -	 1.0	 1.0	 1.0	 -	 -	
NaCl	(mM)	 150	 150	 150	 150	 -	 -	
Tris	pH	8.0	(mM)	 50	 50	 50	 50	 -	 -	
DOC	10%	(%)	 -	 0.5	 0.5	 0.5	 -	 -	
SDS	10%	(%)	 -	 0.1	 0.1	 1.0	 -	 -	
EDTA	pH	8.0	(mM)	 -	 5	 5	 5	 -	 -	
cOmplete	PI	tablet	 1	x	 1	x	 2	x	 2	x	 1	x	 2	x	
PMSF	(mM)	 1	 1	 1		 1	 -	 1	
NaF	(mM)	 5	 5	 10	 10	 -	 2	
BGP	(mM)	 -	 -	 10	 10	 -	 5	
Na2MoO4	(mM)	 -	 -	 10	 10	 -	 5	
Na4P2O7	(mM)	 -	 -	 10	 10	 -	 5	
H2O	to	volume	 ✓ ✓	 ✓	 ✓	 -	 -	
PBS	to	volume	 -	 -	 -	 -	 ✓	 ✓	
a	Suppliers	outlined	in	Chapter	2.6.1.	 	 	 	 	 	 	 	 	
b	Percentages	represent	v/v.	 	 	 	 	 	 	 	 	 	


























Methods	 of	 human	 neutrophil	 isolation	 from	 blood	 using	 density	 gradient	 medium	




were	 routinely	>95%	pure,	where	 this	population	was	 regularly	>97%	CD66b+	 (Figure	3.1C).	





determined	 using	 CD66b-PerCP/Cy5.5	 and	 flow	 cytometry.	 Flow	 cytometry	 events	were	 gated	 for	 (A)	
singlets	 and	 then	 (B)	 neutrophils	 before	 being	 assessed	 for	 (C)	 PerCP/Cy5.5	 fluorescence.	 (A-C)	 Flow	







































In	 contrast,	 screening	 of	 neutrophil	 lysates	 resulted	 in	 limited	 detection	 of	 protein	 bands	
corresponding	 to	 caspase-1	 for	 both	donors	 (Figure	 3.1B).	 Given	 neutrophils	 are	 reported	 to	
display	constitutively	high	caspase-1	expression	(Santos-Beneit	and	Mollinedo,	2000),	reduced	





two	 commonly	 used	 non-ionic	 detergent	 based	 buffers	 were	 compared,	
radioimmunoprecipitation	assay	 (RIPA)	buffer	 and	nonidet	P-40	(NP-40)	buffer.	Additionally,	













(PMN)	 lysates	were	 prepared	 in	RIPA	buffer	 1	 (Table	 3.1)	 following	 60	 and	180	min	 incubations	 and	
caspase-1	assessed	by	immunoblot.	Sample	protein	concentration	was	determined	using	the	DC	Protein	







could	be	 seen	 in	 the	 sonicated	RIPA	1	 lysate	below	15	kDa,	 indicative	of	 protein	degradation	
(Figure	 3.3A).	 Densitometry	 was	 performed	 on	 the	 gel	 images,	 and	 although	 protein	




the	DC	Protein	Assay,	 it	was	selected	over	NP-40	buffer	 for	 further	experiments.	Additionally,	
sonication	was	excluded	in	further	experiments	due	to	sample	degradation.	
Donor 1 THP-1 





50  - 
37  - 
25  - 
20  - 
50  - 
40  - 
30  - 























NP-40	 3.3	(1)	 ND	 ND	 ND	
RIPA	1	 3.3	(2)	 271	 271	 27	
RIPA	1	and	SON	 3.3	(3)	 575	 575	 58	
RIPA	1	 3.4	(1)	 3374	 675	 67	
RIPA	1	and	SS	 3.4	(2)	 3142	 628	 63	
RIPA	2	 3.4	(3)	 2256	 451	 45	
RIPA	2	and	SS	 3.4	(4)	 2368	 474	 47	
RIPA	3	and	SS	 3.4	(5)	 3496	 699	 70	
RIPA	2	and	PBSI	1	 3.5	(1)	 2571	 514	 43	
RIPA	2	and	PBSI	2	 3.5	(2)	 2694	 539	 45	
a	Corresponding	figure	and	lane	are	referenced	and	are	representative	of	one	experiment.	 	 	
b	 Protein	 concentration	 was	 determined	 in	 neutrophil	 (PMN)	 lysates	 using	 the	 DC	 Protein	 Assay	 by	
comparison	to	standards	made	with	bovine	serum	albumin.	 	 	 	 	 	
Abbreviations:	ND,	not	determined;	NP-40,	nonidet	P-40	lysis	buffer;	PBSI,	phosphate	buffered	saline	with	





















loaded	 before	 separation	 by	 SDS-PAGE,	 then	 proteins	 visualised	with	 rapid	 stain	 and	 imaging.	 Visual	











(Figure	3.4B).	The	 greatest	protein	degradation	was	observed	 in	 the	 lysate	prepared	 in	RIPA	
buffer	3	with	sheer	stress	(Figure	3.4B).	The	greatest	protein	preservation	was	observed	for	the	



















































the	absence	or	presence	of	 sheer	stress	 (SS).	Sample	protein	concentration	was	determined	via	 the	DC	
Protein	Assay	and	lysates	were	equally	loaded	then	separated	via	SDS-PAGE.	Protein	bands	were	visualised	









RIPA 1 and SS 
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concentration)	 or	 PBSI	 2	 (containing	 increased	 protease	 and	 phosphatase	 inhibitor	
concentration).	The	protein	concentration	of	neutrophil	lysates	was	unchanged	by	the	choice	of	
PBSI	wash	buffer	when	determined	with	the	DC	Protein	Assay	(Table	3.2	and	Figure	3.5A).	To	
preserve	 sample	 volumes	 and	 improve	 lane	 loading	 consistency,	 neutrophil	 lysates	 were	
separated	 by	 SDS-PAGE	 using	 Tris	 Glycine	 eXtended	 (TGX)	 stain-free	 gels,	 where	 total	 lane	
protein	 was	 determined	 with	 ultraviolet	 activation	 and	 imaging	 (Figure	 3.5B).	 Protein	 was	
detected	in	lysates	prepared	with	both	PBSI	1	and	PBSI	2,	however	increased	protein	bands	were	
evident	when	 neutrophils	were	washed	 in	 PBSI	 2,	 that	 is,	 increased	 inhibitor	 concentrations	
(Figure	3.5B).	Densitometry	was	performed	on	the	gel	images,	where	the	abundance	and	diversity	
of	 protein	 peaks	 in	 lysates	was	 far	 greater	when	prepared	with	 PBSI	 2	 compared	 to	 PBSI	1,	
demonstrated	by	increased	area	under	the	curve	(Figure	3.5C).	Collectively	these	data	indicate	
that	 increased	 inhibitor	 concentrations	 in	 the	 cell	wash	 buffer	 preserve	 a	 greater	 amount	 of	
protein	 in	 neutrophil	 lysates.	 Further	 experiments	 utilised	 these	 optimisations,	 washing	




employed	 to	 detect	 caspase-1	 in	 human	 neutrophils	 at	 multiple	 incubation	 time	 points.	






neutrophil	 lysates	 from	 all	 donors	 the	most	 abundant	 form	 of	 caspase-1	 identified	 was	 p46,	






















was	 determined	 by	 densitometry	 and	 represented	 as	 a	 relative	 value	 in	 order	 to	 compare	
different	donors	(Figure	3.7D).	Relative	detection	of	neutrophil	protein	using	all	three	techniques	
was	shown	to	decrease	over	180	min	(Figure	3.7D).	In	comparison	to	housekeeping	proteins,	total	
B A C 
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(PMNs)	 were	 washed	 with	 PBSI	 2	 then	 lysed	 with	 RIPA	 buffer	 2	 at	 0,	 30,	 60	 and	 180	 min.	 Protein	
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Figure	 3.7:	 Normalisation	methods	 for	 neutrophil	 immunoblot	 using	 total	 protein,	 β-actin	 and	
GAPDH.	 (A)	 Neutrophils	 (PMNs)	 were	 washed	 with	 PBSI	 2	 and	 lysed	 with	 RIPA	 buffer	 2	 following	
incubation	for	0,	30,	60	or	180	min.	Protein	concentration	in	neutrophil	lysates	was	determined	with	the	
DC	Protein	assay	then	20	µg	was	loaded	into	TGX	Stain-Free	gels	and	proteins	separated	by	SDS-PAGE.	(A)	
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2,	 outlined	 in	Table	3.1)	 yielded	 the	 greatest	protein	preservation	 in	neutrophil	 lysates	when	
assessed	by	SDS-PAGE	and	densitometry.	Similarly,	prior	to	neutrophil	lysis,	washing	cells	in	a	
PBS	 buffer	 containing	 inhibitors	 (PBSI	 2)	 further	 improved	 protein	 preservation	 in	 lysates.	
Physical	 methods	 of	 cell	 lysis	 such	 as	 sonication	 and	 sheer	 stress	 did	 not	 increase	 protein	
preservation	but	resulted	in	increased	sample	degradation.	Applying	the	optimised	protocol,	the	
immunoblot	 normalisation	 techniques	 using	 total	 protein	 and	 β-actin	 and	 GAPDH	 by	




















death	 through	 the	 cleavage	 of	 gasdermin	 D	 (GSDMD),	 and	may	 influence	 planned	 cell	 death	
investigations	 (Kambara	 et	 al.,	 2018).	 In	 the	 optimised	 RIPA	 buffer,	 phenylmethylsulfonyl	




the	 product	 recommendation	 (Sigma-Aldrich,	 2020a).	 Due	 to	 product	 patents	 however,	 the	
specific	 chemical	 composition	 within	 each	 tablet	 is	 unknown.	 Protocols	 published	 after	 the	
development	of	this	method	also	address	serine	protease	activity	in	neutrophil	 lysates,	adding	
neutrophil	elastase	inhibitor	BAY-85-8501	for	the	investigation	of	inflammatory	neutrophil	death	
(Sollberger	 et	 al.,	 2018),	 highlighting	 again	 the	 considerations	 that	 must	 be	 taking	 when	




cell	 permeation,	 resulting	 in	 control	 of	 protease	 activity	 prior	 to	 neutrophil	 lysis	 and	 thus	
protection	of	proteins	at	that	point	in	time.	
The	 assessment	of	 normalisation	methods	 for	quantification	of	proteins	 in	neutrophil	 lysates	
revealed	that	housekeeping	proteins	β-actin	and	GAPDH	are	less	reliable	and	consistent	when	
compared	to	total	protein.	This	research	agrees	with	the	body	of	research	previously	mentioned,	
















size	 and	 granularity	 can	 be	 an	 accurate	 tool	 to	 identify	neutrophils.	 Eosinophils	 also	 express	
CD66b	 and	 it	 should	 be	 mentioned	 that	 methods	 using	 gradient	 centrifugation	 such	 as	
polymorphprep	result	in	higher	contamination	with	eosinophils	than	those	that	use	positive	or	
negative	 magnetic	 bead	 isolation	 (Thomas	 et	 al.,	 2015).	 The	 trade-off	 for	 lower	 eosinophil	
contamination	during	neutrophil	isolations	is	the	higher	cost	and	reduced	yield	of	magnetic	bead	
isolation	 (Thomas	 et	 al.,	 2015).	 For	 the	 current	 application,	 cost	 and	 yield	 were	 prioritised.	
Circulating	 eosinophil	 populations	 can	vary	 greatly	 from	donor	 to	donor,	 however	 additional	








human	 neutrophils	 over	 time.	 These	 findings	 and	 methods	 could	 be	 used	 for	 future	 studies	









A	 large	body	of	 research	has	 focused	upon	emm1	strains	of	Streptococcus	pyogenes	 (Group	A	
Streptococcus,	 Group	 A	 Streptococci,	 GAS),	 though	 in	 demographics	 with	 increased	 risk	 and	
burden	 of	 infection	 emm1	 infections	 are	 rare	 (Carapetis	 et	 al.,	 1999)	 and	 GAS	 serotype	
distribution	is	far	more	diverse	with	no	distinct	dominant	strains	(Hassell	et	al.,	2004,	Norton	et	
al.,	 2004,	Richardson	et	 al.,	 2010).	Emm1	GAS	have	been	 shown	 to	have	 a	high	propensity	 to	
acquire	mutations	 in	covRS	 (Walker	 et	al.,	2007),	however	non-emm1	 isolates	have	also	been	
cultured	 from	 invasive	 infections	 that	 have	 naturally	 occurring	 mutations	 in	 covS	 including	
NS88.2	(emm98.1,	 invasive;	blood,	Australia)	 (McKay	et	al.,	2004)	and	A20	(emm23,	 invasive;	
blood,	 Japan)	 (Okamoto	 et	 al.,	 1966).	 Both	NS88.2	 and	 A20	display	 resistance	 to	 neutrophil-
mediated	killing	and	have	a	high	propensity	to	cause	 invasive	disease	 in	vivo	(Maamary	et	al.,	
2010).	 However,	 it	 is	 yet	 to	 be	 elucidated	 if	 invasive	 disease	 caused	 by	 covS	 mutant	 strains	
induces	a	common	neutrophil	phenotype,	independent	of	emm-type.	
During	 severe	 invasive	 infection,	 the	 fate	 of	 neutrophils	 can	 influence	 the	 extent	 of	 the	
inflammatory	response	(Kobayashi	et	al.,	2018).	Inflammatory	neutrophil	death	pathways	may	
be	induced	in	response	to	infection	(Liu	and	Sun,	2019),	where	bacterial	modulation	to	the	fate	










the	 development	 of	 invasive	 infections,	 as	 it	 is	 evident	 that	 during	 severe	 invasive	 disease	
inflammation	is	deregulated	(Johansson	et	al.,	2010).	Therefore,	 this	body	of	research	aims	to	
further	 characterise	 the	 neutrophil	 response	 to	 virulent	 and	 avirulent	 GAS	 in	 a	 non-emm1	
background.	Using	an	in	vitro	human	neutrophil	model,	two	emm98.1	GAS	strains	are	temporally	
described	 for	 their	effect	 cell	death,	signalling	and	 inflammatory	profile.	Further,	we	build	on	
previously	 established	work	 comparing	differences	due	 to	covS	mutation	using	emm98.1	GAS	
(Maamary	et	al.,	2010).	We	propose	that	NS88.2	disrupts	processes	that	promote	the	resolution	














laser	 blue	 (488	 nm).	 Bandpass	 filters	 for	 Zombie	 aqua	 (525/50),	 fluorescein	 isothiocyanate	
(FITC)/green	 fluorescent	 protein	 (GFP)/FAM	 FLICA	 (525/50),	 peridinin-chlorophyll-protein	
(PerCP)-Cyanine	 (Cy)5.5	 (695/40)	R-phycoerythrin	 (PE,	 586/15),	 PE-Cyanine	 (Cy)7	 (780/60)	
and	allophycocyanin	(APC,	670/30)	were	used.	Data	were	analysed	and	presented	using	FlowJo	
software	 V10.6.1	 (TreeStar	 Inc.).	 Compensation	 was	 performed	 by	 single	 staining	 human	
neutrophils	at	the	time	of	peak	CD	expression.	
4.2.3 Statistical	analysis	




the	 nested	 nature	 of	 the	 human	 neutrophil	 Annexin-V/Zombie	 and	 CD	 data	 with	 repeated	
measures	over	time	in	the	same	donor,	a	linear	mixed	model	was	used	to	determine	significant	
interaction	between	 treatment	 and	 time.	Post-hoc	 tests	were	performed	by	multiple	one-way	
ANOVA	 at	 each	 time	 point	 where	 multiple	 comparisons	 were	 adjusted	 using	 Tukey	 HSD	












a	180	min	 time	period,	where	 increased	 survival	of	NS88.2	was	observed	when	 compared	 to	
NS88.2rep	(p<0.05,	Figure	4.1A).	Further,	 in	the	presence	of	viable	human	neutrophils	NS88.2	
showed	 increased	 proliferation	 compared	 to	 NS88.2rep	 (Figure	 4.1A).	 No	 difference	 in	
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compared	 to	 NS88.2rep	 over	 300	 min	 (p<0.05,	 Figure	 4.2D).	 Internalisation	 of	 NS88.2	 by	
neutrophils	was	also	reduced	compared	to	NS88.2rep	at	30	min	(p<0.05,	Figure	4.2E).	Moreover,	
NS88.2rep	 induced	 significantly	 greater	 neutrophil	 reactive	 oxygen	 species	 (ROS)	 production	
compared	to	NS88.2	(Figure	4.2F).	The	rate	of	ROS	production	calculated	between	30-60	min	was	
greater	during	NS88.2rep	infection	(2000	±	540	RFU/min)	when	compared	to	uninfected	(800	±	















E)	 Results	 are	 the	 pooled	means	 ±	 SD	 of	 triplicate	measurements.	 *p<0.05,	 **p<0.01,	 ***p<0.001	 and	
****p<0.0001.	
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To	 investigate	 GAS-induced	 neutrophil	 death,	 human	 neutrophils	 were	 incubated	 with	
NS88.2rep,	NS88.2	or	in	the	absence	of	GAS	and	the	binding	of	annexin-V	(AV),	as	a	measure	of	






significantly	 reduced	 viability	 following	 NS88.2rep	 infection	 compared	 to	 NS88.2	 infection	
(p<0.01,	 Figure	 4.3D).	 Neutrophil	 PS	 exposure	 (AV+Z-)	was	 increased	 only	 during	 NS88.2rep	
incubation	 at	 60	 min	 compared	 to	 uninfected	 neutrophils	 (Figure	 4.3E).	 Neutrophil	 death	
occurred	in	response	to	both	strains,	though	increased	neutrophil	death	was	more	evident	during	
NS88.2rep	infection	when	compared	to	NS88.2	(p<0.05,	Figure	4.3F).	Results	indicate	a	delayed	













Results	 are	 pooled	 means	 ±	 SD	 (n=3	 donors).	 Linear	 mixed	 model	 ‘p’	 values	 represent	 interaction	





To	 further	 explore	 neutrophil	 death	 occurring	 during	 GAS	 infection	 (Figure	 4.3),	 human	
neutrophil	 lysates	 were	 separated	 via	 SDS-PAGE	 and	 screened	 for	 the	 abundance	 of	 active	
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min	 (Figure	4.4A,	C,	D	and	E).	 Infection	of	neutrophils	with	NS88.2rep	significantly	 increased	
caspase-3	p17	at	180	min	(p<0.0001)	and	amounts	of	full-length	caspase-8	(p<0.01)	compared	
to	 uninfected	 and	 NS88.2	 infected	 neutrophils	 (Figure	 4.4A,	 D,	 E).	 Uninfected	 neutrophils	
displayed	reduced	amounts	caspase-1	and	caspase-4	over	180	min	(Figure	4.4B,	F-H).	Infection	
of	neutrophils	with	GAS	increased	pro-caspase-1	amounts	compared	to	uninfected	neutrophils,	
however	 these	 differences	 were	 not	 statistically	 significant	 (Figure	 4.4B	 and	 F).	 Increased	
amounts	of	caspase-1	p46	were	detected	during	infection	with	both	GAS	strains	when	compared	
to	uninfected	neutrophils	 (p<0.0001),	where	NS88.2rep	 infection	 invoked	greater	 amounts	of	
caspase-1	p46	compared	to	NS88.2	(p<0.05,	Figure	4.4B	and	G).	Increased	amounts	of	full-length	








cytometric	 assay	 to	 detect	 active	 caspase-1,	 -4	 and	 -5	 (Figure	 4.5).	 Uninfected	 neutrophils	
exhibited	 decreasing	 inflammatory	 caspase	 activation	 over	 time,	 however	 a	 significant	
interaction	was	only	determined	between	treatments,	not	over	 time	(Figure	4.5D).	NS88.2rep	
invoked	 increased	 inflammatory	 caspase	 activation	 at	 all	 time	 points	 when	 compared	 to	
uninfected	neutrophils	or	NS88.2	infected	neutrophils	(p<0.001,	Figure	4.5D).	In	contrast,	NS88.2	
infection	 invoked	 increased	 inflammatory	 caspase	 activation	 at	180	min	only	 (p<0.05,	 Figure	
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Figure	 4.5:	 GAS	 infection	 activates	 inflammatory	 caspases	 in	 human	 neutrophils.	 Inflammatory	
caspase	activation	during	GAS	infection	was	further	confirmed	in	human	neutrophils	(PMNs)	using	FLICA	




caspase	 activation	was	 determined	 at	 60,	 120	 and	 180	min	 following	 GAS	 infection	 and	 compared	 to	












































































IL-1b	 released	 in	 response	 to	 NS88.2rep	 compared	 to	 NS88.2	 (p<0.0001,	 Figure	 4.6C).	
Neutrophils	also	released	TNF-a	in	response	to	both	GAS	strains	at	180	and	360	min	(p<0.01),	
where	 again	 significantly	 more	 TNF-a	 was	 released	 in	 response	 to	 NS88.2rep	 compared	 to	
NS88.2	at	360	min	(p<0.0001,	Figure	4.6D).	Increased	IL-8	was	detected	at	60	min	in	response	to	
NS88.2rep,	when	compared	to	NS88.2	infected	or	uninfected	neutrophils	(p<0.05,	Figure	4.6E).	



















































N S 8 8 .2 rep
N S 8 8 .2
****





























N S 8 8 .2 re p
N S 8 8 .2
**
****























) P M N
N S 8 8 .2 re p
N S 8 8 .2 *

























) P M N
N S 8 8 .2 re p




A B C 







1996).	 To	 further	 explore	 the	 functionality	 of	 neutrophils	 during	 GAS	 infection,	 human	
neutrophils	were	incubated	in	the	absence	or	presence	of	NS88.2rep	and	NS88.2	and	cell-surface	
expression	of	CD11b,	CD66b,	CD16,	CD31,	CD47	and	CD64	analysed	by	flow	cytometry	(Figure	
4A-F).	 CD16	 (FcγRIII)	 facilitates	 opsonisation	 of	 pathogens	 and	 is	 down-regulated	 during	
apoptosis	(Dransfield	et	al.,	1994,	Fossati	et	al.,	2002),	whilst	down-regulation	of	CD31	(PECAM-
1)	 and	 CD47	 (gp42)	 facilitates	 clearance	 of	 apoptotic	 neutrophils	 and	 the	 resolution	 of	
inflammation	(Brown	et	al.,	2002,	Kurosaka	et	al.,	2003,	Lawrence	et	al.,	2009).	Additionally,	the	
expression	of	CD64	(FcγRI)	on	neutrophils	has	been	used	as	a	biomarker	for	prediction	of	sepsis	
(Barth	 et	 al.,	 2001).	 In	 the	 absence	 of	 GAS,	 or	 following	 incubation	with	NS88.2,	 neutrophils	




NS88.2	 infected	 neutrophils,	 though	 a	 statistical	 difference	 was	 only	 determined	 between	
NS88.2rep	infected	and	uninfected	neutrophils	(p<0.05,	Figure	4.7D).	Infection	with	NS88.2rep	
resulted	 in	 a	significant	decrease	 in	CD16	expression	over	 time	 compared	 to	both	uninfected	
neutrophils	and	those	infected	with	NS88.2	at	30	(p<0.05),	60	(p<0.01)	and	180	min	(p<0.05)	
post	 infection	 (Figure	 4.7E).	 Similarly	 to	 CD16,	 infection	 of	 neutrophils	 with	 NS88.2rep	
significantly	reduced	CD31	expression,	at	60	and	180	min	(p<0.01)	compared	to	NS88.2	(Figure	
4.7F).	 Differences	 in	 the	 expression	 of	 CD47	 and	 CD64	 on	 neutrophils	 were	 not	 observed	
following	any	treatment	(Figures	4.7G	and	H).	Together,	these	data	suggest	that	the	neutrophil	
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to	 emm98.1	 infection	 (Tsatsaronis	 et	 al.,	 2015).	 This	 study	 furthers	 the	 understanding	 of	 the	
human	neutrophil	response	to	GAS,	addressing	neutrophil	death,	cell-surface	signaling	and	the	





conclude	 that	 in	 the	 emm98.1	 genetic	 background,	 GAS	mediated	 activation	 of	 inflammatory	





with	prolonged	neutrophil	 survival	 and	 reduced	bacterial	 killing.	We	 report	 retention	of	 cell-
surface	proteins	CD16	and	CD31	during	infection	with	NS88.2	that	may	impede	the	removal	of	
bacteria	 and	 clearance	 of	 neutrophils	 at	 sites	 of	 infection,	 preventing	 the	 resolution	 of	
inflammation.	
The	 induction	 of	 lytic	 neutrophil	 death,	 as	 inferred	 by	 loss	 of	 cell	 membrane	 integrity,	 has	
previously	 been	 reported	during	 emm1	and	 emm98.1	 GAS	 infection	 (Kobayashi	 et	 al.,	 2003a,	
Tsatsaronis	et	al.,	2015).	The	current	study	identifies	the	activation	of	inflammatory	caspases	in	
neutrophils	 during	 emm98.1	 GAS	 infection,	 supporting	 a	 hypothesis	 that	 an	 inflammatory	






of	phagocytosis.	NS88.2	 is	 highly	 resistant	 to	phagocytosis,	 and	 in	 the	 current	 study,	 reduced	




apoptosis	 (Daigle	 and	 Simon,	 2001).	 A	 homeostatic	 relationship	 between	 apoptotic	 and	
inflammatory	pathways	is	thought	to	effectively	facilitate	the	resolution	of	inflammation,	during	
the	 removal	 of	 bacterial	 pathogens	 (Lawrence	 et	 al.,	 2020).	 Disruption	 to	 this	 homeostatic	
balance,	as	demonstrated	during	NS88.2	infection,	may	therefore	be	a	contributing	factor	to	the	
development	of	invasive	disease.	







with	NS88.2,	 can	hinder	 the	process	of	 efferocytosis	 (Brown	et	 al.,	 2002),	 limiting	neutrophil	
removal	by	macrophages	(Kurosaka	et	al.,	2003)	and	contributing	to	cellular	crowding	at	the	site	
of	 infection.	 Infection	of	neutrophils	with	 gram	positive	 cocci	Staphylococcus	 aureus	has	been	
shown	 to	 prevent	macrophage	 efferocytosis	 (Greenlee-Wacker	 et	 al.,	 2014).	 Neutrophil	 CD31	
retention	may	have	a	similar	effect	during	GAS	infection,	although	this	was	not	explored	in	the	
current	study.	Moreover,	neutrophils	infected	with	NS882	retained	CD16,	which	functions	as	a	








neutrophil	 function	 and	 inflammatory	 death	 as	 contributing	 factors	 to	 disease	 development	
(Bergsbaken	and	Cookson,	2009,	Holzinger	et	al.,	2012,	Ryu	et	al.,	2017).	In	murine	neutrophils,	
virulent	GAS	survive	intracellularly,	evading	host	defences	and	using	the	inflammatory	response	
for	 a	 competitive	 advantage	 to	 disseminate	 and	 increasing	 virulence	 (Medina	 et	 al.,	 2003a,	
Medina	et	al.,	2003b).	These	and	other	studies	support	the	hypothesis	that	neutrophil	death	may	
also	contribute	to	the	development	of	invasive	GAS	disease	(Kobayashi	et	al.,	2003a,	Tsatsaronis	





induce	 inflammatory	 caspase	 activation	 and	 cytokine	 release	 (Chapter	 5),	 while	 reduced	
neutrophil	apoptosis	occurs	 in	response	 to	strains	that	are	highly	virulent	 in	vivo	 (Chapter	6)	
(Tsatsaronis	 et	 al.,	 2015).	 A	 homeostatic	 relationship	 between	 apoptotic	 and	 inflammatory	
neutrophil	death	 is	believed	 to	determine	 the	control	of	bacterial	 infections	(Kobayashi	et	al.,	
2018,	 Lawrence	 et	 al.,	 2020).	 Disruption	 to	 this	 relationship	 is	 now	 observed	 in	 response	 to	
emm98.1	and	will	be	 further	explored	 in	response	to	emm1	GAS	(Chapter	5).	As	 invasive	GAS	




the	 function	of	neutrophils	during	 the	early	stage	of	 infection	can	greatly	 influence	outcomes.	
Here,	 evidence	 is	 provided	 to	 show	 that	 neutrophil	 function	 is	 altered	 during	 infection	with	
emm98.1	 GAS	 strain	NS88.2,	 isolated	 from	 invasive	 disease.	 Alterations	 to	 anti-inflammatory	





resolution	 of	 infection,	 whilst	 inflammatory	 neutrophil	 death	 and	 cytokine	 release	 promote	
further	 inflammation.	 The	 demonstration	 that	 diverse	 GAS	 serotypes	 are	 associated	 with	
inflammatory	 caspase	 activation	 in	 neutrophils	 supports	 the	 need	 to	 further	 explore	
inflammasome	 activation	 in	 response	 to	 GAS.	 Disruption	 to	 the	 equilibrium	 of	 apoptotic	 and	
























et	 al.,	 2007).	 Used	 in	 tandem,	 these	 two	 strains	 have	 been	 employed	 as	 a	model	 to	 explore	






and	 subsequent	 inflammation	 (Lawrence	 et	 al.,	 2020).	 Previous	work	 outlines	 how	GAS	 take	






emm1	 GAS	 has	 previously	 been	 established	 (Kobayashi	 et	 al.,	 2003a),	 yet	 requires	 further	
characterisation.	 Models	 to	 further	 investigate	 leukocyte	 inflammatory	 cell	 death	 have	 been	
proposed	 (Tran	 et	 al.,	 2019),	 but	 not	 implemented	 in	 GAS	 research.	 Here,	 primary	 human	
neutrophils	have	been	infected	with	GAS	to	determine	if	inflammatory	neutrophil	death	may	be	
a	contributing	factor	to	the	development	of	invasive	disease.		
Although	 emm1	GAS,	 particularly	 5448,	 is	 the	 focus	 of	 a	 large	 amount	 of	 research,	 a	 limited	
number	 of	 studies	 have	 investigated	 the	 neutrophil	 response	 to	 emm1	 GAS	 specifically	
(Kobayashi	 et	 al.,	 2003a).	 This	 body	 of	 research	 aims	 to	 further	 characterise	 the	 neutrophil	
response	to	virulent	and	hypervirulent	GAS	of	emm1	background.	Specifically,	using	an	in	vitro	
model	 of	 human	neutrophil	 infection,	we	 temporally	describe	 the	 effect	GAS	 stains	5448	and	















laser	 blue	 (488	 nm).	 Bandpass	 filters	 for	 Zombie	 aqua	 (525/50),	 fluorescein	 isothiocyanate	
(FITC)/green	 fluorescent	 protein	 (GFP)/FAM	 FLICA	 (525/50),	 peridinin-chlorophyll-protein	
(PerCP)-Cyanine	 (Cy)5.5	 (695/40)	R-phycoerythrin	 (PE,	 586/15),	 PE-Cyanine	 (Cy)7	 (780/60)	
and	allophycocyanin	(APC,	670/30)	were	used.	Data	were	analysed	and	presented	using	FlowJo	
software	 V10.6.1	 (TreeStar	 Inc.).	 Compensation	 was	 performed	 by	 single	 antibody	 staining	
human	neutrophils	at	the	time	of	peak	CD	expression.	
5.2.3 Statistical	analysis	


















Neutrophil	 phagocytic	 killing	 is	 a	 predominant	 and	 well-established	 mechanism	 of	 immune	
defence.	The	covS	mutant	5448AP	has	previous	shown	increased	resistance	to	neutrophil	killing	
(Walker	 et	 al.,	 2007).	 Similarly	 here,	 5448AP	 is	 resistant	 to	 neutrophil	 mediated-killing	 and	
proliferates	after	120	min	compared	to	5448	(p<0.01,	Figure	5.1A).	Further,	in	the	presence	of	















variants	were	 used	 and	 bacterial	 association	 to	 neutrophils	was	 assessed	 by	 flow	 cytometry	
(Figure	5.2A-D).	GAS	rapidly	associated	 to	human	neutrophils,	with	near	maximal	association	
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internalised	 by	 neutrophils	 than	 5448AP	 at	30	min	 (p<0.05,	 Figure	 5.2E).	 5448	 and	 5448AP	
infection	induced	ROS	production	in	neutrophils,	though	increased	ROS	production	was	observed	
during	5448	 infection	when	compared	 to	uninfected	and	5448AP	 infected	neutrophils	(Figure	
5.2F).	As	such,	the	rate	of	ROS	production	calculated	between	30-60	min	was	greater	during	5448	
infection	(1600	±	580	RFU/min)	when	compared	to	uninfected	(400	±	220	RFU/min)	and	5448AP	
infected	 neutrophils	 (700	 ±	 230	 RFU/min)	 (p<0.01).	 Collectively,	 these	 data	 indicate	 that	
compared	to	5448,	5448AP	associates	less	readily	with	human	neutrophils	and	is	 less	readily	

























viable	 neutrophils	 and	 (C)	 bacterial	 association	 determined	by	 fluorescence.	Flow	 cytometry	 plots	 are	
representative	and	show	(A-B)	5448	 infected	neutrophils	at	60	min	and	(C)	uninfected	 (purple),	5448	
(blue)	and	5448AP	(red)	infected	neutrophils	at	60	min	from	one	donor.	(D)	GAS	association	to	human	
neutrophils	 over	 300	min	 (n=6	donors,	 Student’s	 t-test).	 (E)	The	 internalisation	 of	GAS	by	 neutrophils	
determined	 by	 gentamicin	 protection	 assay	 (n=5	 donors,	 Student’s	 t-test).	 (F)	 ROS	 production	 in	 the	










amounts	 of	 caspase-8	 over	 180	 min	 (Figure	 5.4A,	 C-E).	 Infection	 of	 neutrophils	 with	 5448	
significantly	 increased	 the	 presence	 of	 caspase-3	 p17	 at	 180	min	 compared	 to	 both	 5448AP	
infected	 and	 uninfected	 neutrophils	 (p>0.0001,	 Figures	 5.4A	 and	 D).	 Full	 length	 caspase-8	
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increased	 during	 5448	 infection	 (p<0.01),	 but	 not	 5448AP	 infection,	 when	 compared	 to	









was	 no	 significant	 difference	 in	 expression	 of	 caspase-1	 when	 comparing	 5448	 and	 5448AP	
infected	neutrophils.	 Infection	of	neutrophils	with	5448	 increased	caspase-4	expression	at	30	
(p<0.01),	60	(p<0.001)	and	180	min,	compared	to	uninfected	neutrophils	(p<0.0001,	Figures	5.4B	





infection.	 To	 explore	 this	 possibility	 further,	 human	 neutrophils	 were	 incubated	 with	 5448,	
5448AP	or	in	the	absence	of	GAS	and	inflammatory	caspase-activity	assessed	using	a	fluorogenic	
flow	 cytometric	 assay	 that	 detects	 active	 caspase-1,	 -4	 and	 -5	 (Figure	 5.5).	 Compared	 to	
uninfected	 neutrophils,	 5448	 infected	 neutrophils	 showed	 increased	 inflammatory	 caspase-
activity	at	60	and	180	min	(p<0.05),	whilst	5448AP	infection	increased	inflammatory	caspase-
activity	 at	 180	min	 (p<0.05,	 Figure	 5.5D).	 No	 significant	 differences	were	 observed	 between	
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via	 immunoblotting.	 (A-B)	 Images	 shown	 are	 from	 a	 single	 donor	 and	 are	 representative	 of	 triplicate	
experiments	 using	 different	 donors.	 SE=short	 exposure,	 LE=long	 exposure.	 Immunoblot	 bands	 were	
further	quantified	(ImageJ)	and	normalised	against	total	protein	to	determine	the	amount	of	(C)	full	length	
caspase-3,	(D)	caspase-3	p17,	(E)	full	length	caspase-8,	(F)	full	length	caspase-1,	(G)	caspase-1	p46,	(H)	and	
full	 length	 caspase-4.	 Results	 are	 the	 pooled	 means	 ±	 SD	 from	 3	 separate	 donors.	 *p<0.05,	 **p<0.01,	
***p<0.001	 and	 ****p<0.0001,	with	 black	 denoting	 significance	 to	 control	 and	 grey	 between	5448	 and	
5448AP.
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Figure	 5.5:	 GAS	 infection	 activates	 inflammatory	 caspases	 in	 human	 neutrophils.	 Inflammatory	
caspase	activation	during	GAS	infection	was	further	confirmed	in	human	neutrophils	(PMNs)	using	FLICA	









The	 release	 of	 the	 inflammatory	 cytokine	 IL-1β	 can	 occur	 due	 to	 caspase-1	 activation	 and	 is	
associated	with	 the	 induction	 of	 pyroptosis	 (Broz	 et	 al.,	 2010).	 The	 uncoordinated	 release	 of	
various	inflammatory	cytokines	however,	can	exacerbate	infection	(Tecchio	et	al.,	2014).	During	
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absence	 of	 GAS	and	 supernatants	 assessed	 for	 cytokines	 using	 a	 flow	 cytometric	 bead	assay.	












data	 indicate	 that	 both	 5448	 and	 5448AP	 induce	 IL-1β	 release	 from	 human	 neutrophils,	
consistent	 with	 the	 hypothesis	 that	 both	 GAS	 strains	 may	 induce	 pyroptosis	 in	 these	 cells.	
Moreover,	the	results	indicate	differential	cytokine	release	from	human	neutrophils	infected	with	

















human	 neutrophils	 were	 incubated	 with	 5448,	 5448AP	 or	 in	 the	 absence	 of	 GAS	 and	 the	
expression	of	cell-surface	CD11b,	CD66b,	CD16,	CD31,	CD47	and	CD64	was	assessed	using	flow	
cytometry	(Figure	5.7).	In	the	absence	of	GAS,	neutrophils	displayed	minor	increases	in	CD11b	
expression	over	 time.	 In	contrast,	 incubation	with	GAS	resulted	in	minor	decreases	over	 time,	
with	5448	 inducing	 a	 greater	 loss	of	CD11b	 than	5448AP,	 though	 these	differences	were	not	
statistically	 significant	 (p=0.289,	 Figure	 5.7C).	 Neutrophils	 incubated	 in	 the	 absence	 of	 GAS	
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both	 CD16	and	 CD31	 occur	 in	 neutrophils	due	 to	 GAS	 infection	 in	 vitro.	 CD16	 functions	 as	 a	
receptor	for	opsonised	bacteria	and	immune	complexes	(Fossati	et	al.,	2002),	whilst	the	loss	of	















affected	 during	 GAS	 infection.	 Down-regulation	 of	 CD11b	 can	 prevent	 accumulation	 of	















infection.	 However,	 consistent	 with	 previous	 in	 vivo	 studies	 of	 non-emm1	 covS	mutant	 GAS	
(Tsatsaronis	et	al.,	2015),	the	release	of	the	inflammatory	cytokine	IL-1β,	a	hallmark	of	clinical	





essential	 for	 IL-1β	 release	 (Schneider	 et	 al.,	 2017).	The	 activation	of	 caspase-1/inflammatory	
caspases	in	human	neutrophils	does	not	correlate	directly	to	the	amount	of	IL-1β	released,	and	






Previous	 studies	 have	 characterised	 differences	 between	 5448	 and	 5448AP,	 demonstrating	
resistance	 to	 neutrophil-mediated	 killing	 in	 vitro	 and	 increased	 bacterial	 dissemination	 and	
decreased	 survival	 in	 vivo	 following	 the	 acquisition	 of	 covS	 mutations	 (Fiebig	 et	 al.,	 2015,	
Maamary	 et	al.,	 2010,	Walker	 et	al.,	 2007).	Here	we	 show	 that	neutrophil	death	 is	 delayed	 in	
response	to	covS	mutant	5448AP,	suggesting	extended	neutrophil	viability	during	the	early	stages	
of	 infection.	 Apoptosis	 occurs	 following	phagocytic	 uptake,	 thus,	 delayed	 neutrophil	 death	 in	
response	 to	 5448AP	 compared	 to	 5448	 may	 be	 due	 to	 reduced	 neutrophil	 association	 and	
phagocytosis	 of	 5448AP.	 Alternatively,	 5448AP	 may	 inhibit	 cell	 death	 pathways	 via	 another	
mechanism.	We	demonstrate	that	5448AP	is	not	only	resistant	to	neutrophil-mediated	killing	but	
proliferates	 in	 the	 presence	 of	 functional	 neutrophils.	 GAS	 survival	 has	 been	 demonstrated	
intracellularly	in	murine	neutrophils	and	human	macrophages	(Medina	et	al.,	2003a,	Medina	et	
al.,	2003b,	O’Neill	et	al.,	2016)	and	can	even	be	facilitated	by	host	red	blood	cells	(Wierzbicki	et	
al.,	 2019).	 Increased	 5448AP	 proliferation	 may	 result	 from	 the	 reduction	 in	 neutrophil	 ROS	
response	during	infection.	GAS	has	previously	been	shown	to	display	resistance	to	ROS	through	
numerous	 virulence	 mechanisms	 (Henningham	 et	 al.,	 2015).	 The	 absence	 of	 a	 hostile	
environment	may	further	permit	bacterial	replication.	Additionally,	the	increased	production	of	
ROS	can	induce	neutrophil	death	via	apoptosis	(Geering	and	Simon,	2011).	Reduced	neutrophil	





caspase-3	 activation	 (apoptosis).	 Previously	 it	 has	 been	 demonstrated	 that	 GAS	 emm1	 strain	
MGAS5005	modulates	neutrophil	apoptosis	(Kobayashi	et	al.,	2003a)	and	 that	non-emm1	GAS	
harbouring	 covS	mutation	 elicit	 non-apoptotic	 neutrophil	 death	 (Tsatsaronis	 et	 al.,	 2015),	 a	
finding	which	is	supported	by	the	current	study.	
Changes	 to	 the	 function	 of	 neutrophils	 during	 the	 initial	 innate	 immune	 response	 have	 the	




activation	 and	 death	 via	 pyroptosis.	 However,	 markers	 of	 alternative	 cell	 death	 pathways	
including	necroptosis	and	NETosis	were	not	explored	in	the	current	study,	and	as	such	further	














6 Characterising	 the	 response	of	neutrophils	 to	Group	A	










C57BL/6J	mice	 drives	 the	 formation	 of	 necrotic	 lesions,	 invoking	 inflammation	 including	 the	
recruitment	 of	 immune	 cells	 such	 as	 neutrophils	 (Krishnan	 et	 al.,	 2016,	 Lei	 et	 al.,	 2019,	
Tsatsaronis	et	al.,	2015),	similar	to	the	response	seen	clinically	during	invasive	disease	in	humans	
(Stevens	and	Bryant,	2017).	Detailed	characterisation	of	the	responding	immune	cells,	including	




clearance	 during	 the	 early	 stages	 of	 infection.	 Murine	 neutrophils	 differ	 from	 their	 human	
counterparts	and	are	typically	characterised	by	the	expression	of	Ly-6G	(Stackowicz	et	al.,	2020).	














2011).	 In	particular,	 inflammatory	monocytes	(iMOs)	account	 for	2-5%	of	circulating	immune	
cells	 in	 healthy	 mice	 and	 rapidly	 move	 to	 sites	 of	 infection,	 where	 they	 have	 both	
proinflammatory	and	antimicrobial	roles	(Geissmann	et	al.,	2003,	Serbina	et	al.,	2008).	Murine	





play	 an	 important	 role	 in	 innate	 immunity	 during	 bacterial	 infection	 and	 have	 long	 been	
characterised	 in	mice	by	 flow	cytometry	using	 the	marker	F4/80	(Austyn	and	Gordon,	1981).	
Using	 a	model	 of	macrophage	depletion,	 it	 has	been	demonstrated	 that	macrophages	play	 an	
essential	role	in	the	control	of	soft-tissue	GAS	infection	in	mice	(Goldmann	et	al.,	2004,	Mishalian	
et	 al.,	 2011).	 Further,	 a	 recent	 comprehensive	 review	 outlines	 that	 GAS	 can	 escape	 from	
macrophage	killing	and	influence	inflammation,	which	in	turn	contributes	to	disease	progression	
(Valderrama	and	Nizet,	2018).	
Neutrophils	 have	 been	 the	 primary	 focus	 of	 this	 thesis,	 and	 hence	 this	 chapter	 aims	 to	
characterise	the	neutrophil	response	to	emm1	GAS	in	vivo.	Additionally,	iMOs	and	macrophages	
will	also	be	characterised	for	their	response	to	emm1	GAS	in	vivo.	Using	a	6	and	24	h	murine	model	


























of	 GAS	 strains	 5448	 and	 5448AP	 were	 prepared	 from	 overnight	 culture	 (Chapter	 2.2)	 and	
resuspended	in	0.7%	(w/v)	NaCl	(Sigma-Aldrich)	solution	at	a	concentration	of	1	x	109	CFU/mL.	
Mice	were	briefly	anesthetised	via	isoflurane	inhalation	(4%	induction,	2%	maintenance)	using	a	















immune	cell	 flow	cytometric	analysis.	Blood	 for	serum	was	allowed	to	clot	 for	1	h	at	RT	then	
placed	on	ice	until	further	processing.	The	remaining	blood	was	mixed	with	anticoagulant,	20	µL	
0.5%	(w/v)	sodium	citrate	(Sigma-Aldrich)	per	mL	of	blood,	in	a	1.5	mL	tube	and	placed	on	ice	
until	 further	processing.	 Images	of	the	 injection	site	were	 taken	 for	some	mice	 following	24	h	
infection.	Following,	both	sites	of	injection	were	lavaged	with	1	mL	of	0.7%	NaCl	solution,	where	
fluid	from	the	left	and	right	flanks	was	pooled	into	one	2	mL	tube.	A	10	μL	aliquot	was	taken	and	





























(440/50),	 VL2	 (512/25),	 VL3	 (603/48),	 VL4	 (710/50),	 BL1	 (530/30),	 YL1	 (585/16),	 YL3	
(695/40),	YL4	(780/60)	and	RL2	(720/30)	were	used.	Data	were	analysed	and	presented	using	










FBS,	 where	 fluorochrome	 conjugated	 antibodies	 r-phycoerythrin	 (PE)/Cyanine	 (Cy)5-CD11b,	











Table	 6.1:	 Fluorochrome	 conjugated	 antibodies	 and	 fluorescent	 dyes	 used	 in	 for	 in	 vivo	
experiments	in	this	thesis.	
Conjugated	antibody/Dye	 Company	 Product	#/Clone	 Volume	per	sample	(μL)	
PE/Cy5	anti-mouse/human	CD11b	 BioLegend	 101210/M1-70	 1	
FITC	anti-mouse	CD16	 BioRad	 MCA5998F/AT154-2	 1	
PE/Cy7	anti-mouse	CD31	 BioLegend	 102417/390	 1	
BV421	anti-mouse	CD45	 BioLegend	 103134/30-F11	 0.5	
BV711	anti-mouse	F4/80	 BioLegend	 123147/BM8	 1	
BV605	anti-mouse	Ly-6C	 BioLegend	 128035/HK1.4	 0.5	
PE	anti-mouse	Ly-6G	 BioLegend	 127607/1A8	 0.5	
FLICA	660-YVAD-FMK	 ICT	 ICT9122/-	 0.33	




Serum	 cytokines	were	 determined	 using	 the	 LEGENDplex™	mouse	 inflammation	 panel	 bead-
based	immunoassay	(interleukin	(IL)-1β,	type	I	interferon	(IFN)-β,	IFN-γ,	tumour	necrosis	factor	
(TNF)-α,	monocyte	chemoattractant	protein	(MCP)-1,	IL-6,	IL-10,	IL-12p70,	IL-17A,	IL-23,	IL-27,	
IL-33	and	granulocyte-macrophage	colony-stimulating	 factor	(GM-CSF))	 (BioLegend)	and	 flow	






















analysed	 by	 one-way	 ANOVA	 (Kruskal	 Wallis	 test,	 denoted	 by	 ‘kp’)	 with	 Dunn’s	 multiple	
comparison	or	using	Welch’s	t-test	(unpaired,	denoted	by	‘wp’).	For	all	tests	Gaussian	distribution	
was	 assumed,	 although	 tests	 of	 normality	were	 not	 performed	 due	 to	 the	 small	 sample	 size.	
Statistical	test	were	used	to	compare	treatment	groups	when	they	were	comprised	of	three	of	

























gating	 strategy	 characterised	 neutrophil	 (CD45+/CD11b+/Ly-6G+),	 iMO	 (CD45+/CD11b+/Ly-











manifestations	 and	 bacterial	 loads	 assessed	 at	 6	 and	 24	 h.	 (A)	 Mouse	 body	 weight	 during	 infection,	
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inflammatory	 monocytes	 and	 macrophages.	 (A)	 Following	 injection	 with	 saline,	 5448	 or	 5448AP,	
immune	cells	were	selected	in	blood	(shown)	and	lavage	fluid	(not	shown)	as	‘singlets’	(FSC-A	vs.	FSC-H)	








































































































observed,	 regardless	 of	 injection	 type	 or	 time	 (Figure	 6.3B).	 GAS	 infection	 induced	 minor	
increases	 to	 blood	 neutrophil	 inflammatory	 caspase	 activation,	 however	 statistical	 difference	
from	the	saline	control	was	not	reached	upon	post-hoc	analysis	(Figure	6.3C,	p>0.05).	Infection	
of	mice	with	either	GAS	strain	increased	neutrophil	populations	at	sites	of	injection	(lavage	fluid)	
at	 both	6	and	24	h	 compared	to	 the	 saline	 control	 (p<0.001),	where	 the	 response	 to	5448AP	
appeared	sustained	over	24	h	(Figure	6.3D).	Neutrophil	death	was	increased	in	response	to	GAS	
infection	at	24	h,	compared	to	saline	injected	mice	(p<0.01,	Figure	6.3E).	Infection	of	mice	with	
5448AP,	 but	 not	 5448,	 increased	 inflammatory	 caspase	 activation	 at	 6	 h	 compared	 to	 saline	






CD31	 expression	 at	 6	 and	24	 h	 by	 flow	 cytometry	 (Figure	 6.4).	 Blood	 neutrophils	 from	mice	
injected	with	saline	displayed	consistent	CD11b	expression	at	6	and	24	h,	which	was	unchanged	
by	injection	with	either	GAS	strain	(Figure	6.4A).	The	expression	of	CD16	on	blood	neutrophils	






In	 contrast	 to	 blood	 samples,	 low	 neutrophil	 numbers	 and/or	 low	 cell	 viability	 at	 the	 site	 of	
infection	was	observed	 (Figures	6.3D-E)	 and	values	with	 low	 cell	 counts	were	 excluded	 from	
analysis	(outlined	in	Appendix	G).	Infection	with	either	GAS	strain	increased	lavage	neutrophil	
CD11b	 expression	 at	 6	 h	 compared	 to	 saline	 injection,	where	 expression	 decreased	 by	 24	 h,	
though	differences	were	not	statistically	significant	between	treatments	(Figure	6.4D,	p=0.1782).	
Neutrophils	 lavaged	 from	 the	 site	 of	 5448	 injection	 displayed	 increased	 CD16	 expression	
compared	to	saline	 injection	(p<0.01),	which	by	24	h	had	significantly	decreased	(wp=0.0012,	
Figure	 6.4E).	 Neutrophils	 lavaged	 from	 the	 site	 of	 saline	 injection	 displayed	 variable	 CD31	
expression	at	6	h,	with	no	significant	differences	in	expression	following	infection	with	either	GAS	
strain	at	6	h,	or	for	5448	between	6	and	24	h	(Figure	6.4F).	These	data	show	that	neutrophils	
display	 consistent	 CD11b,	 CD16	 and	 CD31	 in	 the	 circulation	 during	 GAS	 infection,	 though	
differences	are	measurable	at	the	site	of	infection.	






Two-way	 ANOVA	 ‘p’	 values	 represent	 interaction	 (treatment*time)	 or	 are	 stated.	 *p<0.05,	 **p<0.01,	
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Figure	 6.4:	 Neutrophil	 function	 during	 in	 vivo	 GAS	 infection	 can	 be	 tracked	 by	 cell-surface	 CD	
expression.	Following	injection	with	saline,	5448	or	5448AP,	cells	were	characterised	by	flow	cytometry	
(Figure	 6.2).	Neutrophil	 populations	 (CD45+/CD11b+/Ly-6G+)	 in	 the	 (A-C)	 blood	 and	 (D-F)	 lavage	 fluid	
were	assessed	for	the	cell-surface	expression	of	(A	and	D)	CD11b-PE/Cy5,	(B	and	E)	CD16-FITC	and	(C	and	
F)	 CD31-PE/Cy7.	 Each	 data	 point	 represents	 the	 results	 from	 a	 single	 mouse	 where	 n=8	 and	 mean	
fluorescence	intensity	(MFI)	is	shown.	Results	are	the	means	±	SD.	One-way	ANOVA	(Kruskal	Wallis	test)	








following	 all	 treatments	 at	 both	 times	 (Figure	 6.5B).	 Blood	 iMOs	 displayed	 moderate,	 but	
consistent	inflammatory	caspase	activation,	with	no	significant	differences	determined	between	
any	 groups	 upon	 post-hoc	 analysis	 (Figure	 6.5C,	 p>0.05).	 At	 the	 site	 of	 saline	 injection	 iMO	
populations	were	observed	in	response	to	all	treatments,	however	populations	were	sustained	in	
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caspase	 activation	 in	 iMOs	was	 similar	 in	 all	 three	 groups	 at	 6	 h,	 however	 both	 GAS	 strains	
increased	inflammatory	caspase	activation	in	iMOs	at	24	h	compared	to	saline	(p<0.05,	Figure	
6.5F).	 Collectively,	 in	 vivo	 GAS	 infection	 invokes	 recruitment	 of	 iMOs	 to	 the	 site	 of	 injection,	
resulting	in	cell	death	and	inflammatory	caspase	activation.	
	













strain	 increased	 CD11b	 expression	 on	 blood	 iMOs	 at	 6	 (p<0.05)	 and	 24	 h	 (p<0.01)	 when	
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was	 investigated	 using	 flow	 cytometry.	 The	 percent	 of	 blood	 macrophages	 was	 unchanged	
following	 all	 treatments	 (Figure	 6.7A).	 High	 blood	 macrophage	 death	 was	 observed	 for	 all	
treatments	at	both	time	points	(Figure	6.7B).	Blood	macrophages	displayed	moderate	and	similar	
amounts	of	inflammatory	caspase	activation	following	saline	or	GAS	injection	at	both	6	and	24	h	
(Figure	 6.7C).	 Similar	 proportions	 of	 macrophages	 were	 present	 at	 the	 lavage	 site	 following	
injection	with	 saline	 or	 GAS	 (Figure	 6.7D).	 High	macrophage	death	was	 also	 observed	 at	 the	






















and	 CD31	 expression	 at	 6	 and	 24	 h	 by	 flow	 cytometry	 (Figure	 6.8).	 Due	 to	 low	macrophage	
numbers	and/or	low	cell	viability	(Figures	6.7A-B	and	D-E)	some	data	points	were	excluded	from	
analysis	 (outlined	 in	 Appendix	 G).	 The	 expression	 of	 CD11b,	 CD16	 and	 CD31	 on	 blood	
macrophages	was	similar	following	saline	or	GAS	injection	at	both	6	and	24	h	(Figure	6.8A-C).	
Due	to	the	limited	number	or	complete	absence	of	data	points	obtained	for	lavage	macrophages,	
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and	 24	 h	 and	 5448AP	 at	 6	 h	 (Figure	 6.8D).	 The	 expression	 of	 CD16	 on	 lavage	macrophages	
following	5448	injection	at	6	h	was	increased	compared	to	5448AP,	where	expression	decreased	
in	 response	 to	5448	 by	 24	 h	 (Figure	 6.8E).	 Finally,	 CD31	 expression	 on	 lavage	macrophages	
following	5448	injection	was	greater	than	5448AP	at	6	h,	where	expression	increased	in	response	
to	 5448	 by	 24	 h	 (Figure	 6.8F).	 The	 response	 of	 macrophages	 during	 GAS	 infection	 is	 well	
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bead	 populations	 A	 and	 B	 were	 selected	 by	 FSC-A	 and	 SSC-A	 (Figure	 6.9A),	 where	 cytokine	
concentrations	were	determined	by	PE	and	APC	fluorescence	(Figure	6.9B)	and	comparison	to	a	
standard	 curve	 (Appendix	 D).	With	 the	 exception	 of	 IL-6	 and	MCP-1,	 serum	 cytokines	 were	
present	in	the	majority	of	saline	injected	mice	at	6	h	with	a	rate	order	of	IL-27	>	IFN-β	>	IL-23	>	
IFN-γ	 >	 IL-10	 =	 TNF-α	 >	 IL-1β	 >	 GM-CSF	 >	 IL-17A	 >	 IL-1α	 >	 IL-12p70	 (Figure	 6.9C-O).	 The	
presence	of	these	cytokines	in	saline	injected	mice	was	similar	at	24	h	compared	to	6	h	(Figure	
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(p<0.01,	 Figure	 6.9L)	 and	 TNF-α	 (p<0.001,	 Figure	 6.9O).	 Additionally,	 injection	with	 5448AP	
significantly	 increased	 IFN-γ	 (p<0.0001,	 Figure	 6.9E),	 IL-1β	 (p<0.0001,	 Figure	 6.9G),	 IL-6	
(p<0.0001,	Figure	6.9H),	 IL-10	(p<0.001,	Figure	6.9I),	 IL-12p70	(p<0.001,	Figure	6.9J),	 IL-17A	
(p<0.0001,	Figure	6.9K)	and	TNF-α	(p<0.0001,	Figure	6.9O)	at	24	h	when	compared	 to	5448.	
Collectively	 both	 GAS	 strains	 induce	 some	 cytokine	 release,	 however	 5448AP	 is	 generally	












(M)	 IL-27,	 (N)	 MCP-1	 and	 (O)	 TNF-α	 was	 determined	 by	 comparison	 to	 a	 standard	 curve.	 Duplicate	
measurements	from	each	mouse	are	displayed,	where	n=8	mice	were	used	for	each	treatment/time.	Results	
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longer	 at	 the	 site	 of	 5448AP	 injection	 than	 5448.	 Neutrophils	 died	 in	 response	 to	 GAS	 and	










emm1	GAS	 infection,	where	 inflammatory	caspase	activation	 is	evident.	Caspase-1	is	 the	most	
notable	 inflammatory	 caspase,	 as	 it	 is	 primarily	 recognised	 for	 its	 role	 during	 the	 release	 of	
inflammatory	 cytokine	 IL-1β	(Man	et	al.,	 2017).	The	 activation	of	 inflammatory	 caspases	was	
similar	in	neutrophils	and	iMOs	when	comparing	GAS	strains	5448	and	5448AP.	In	contrast,	the	
release	of	IL-1β	into	the	serum	differed	between	these	two	strains,	with	increased	IL-1β	release	




















be	 an	 indicator	 of	 the	 severity	 of	 GAS	 infection	 (Norrby-Teglund	 et	 al.,	 2000).	 The	 increased		





development	 of	 sepsis	 and	 increased	 mortality	 during	 invasive	 infections	 (Sriskandan	 and	
Altmann,	2008).	
The	current	study	identifies	differences	in	CD16	expression	on	murine	neutrophils	during	GAS	













the	 clearance	 of	 infection	 (Fine	 et	 al.,	 2019),	 but	 are	 also	 associated	 with	 the	 inflammatory	
pathway	 that	 produces	 NETs	 (Cerutti	 et	 al.,	 2013).	 Similarly,	 it	 was	 hypothesised	 that	 CD31	
expression	would	 change	 in	 response	 to	 GAS	 infection,	 however	 this	was	 not	 observed.	 It	 is	
possible	 that	 like	 in	humans,	 the	down	 regulation	of	CD31	may	also	promote	 efferocytosis	 of	
neutrophils	(Brown	et	al.,	2002),	however	as	this	occurs	as	a	product	of	cell	death,	an	earlier	time	
point	with	 increased	neutrophil	viability	may	yield	results	 that	better	reflect	 in	vitro	 findings.	
Although	there	are	some	distinct	differences	in	gene	profiles	between	humans	and	mice,	it	is	also	
accepted	that	they	are	broadly	conserved	(Ingersoll	et	al.,	2010).	It	is	possible	that	the	presence	
of	 a	 more	 complete	 and	 dynamic	 immune	 response	 in	 vivo	 or	 interspecies	 differences,	 may	








increased	 CD16	 expression.	 Monocytes	 that	 exhibit	 CD16	 expression	 are	 a	 subset	 of	 ‘non-
























the	 upregulation	 of	 the	 inflammatory	 response,	 as	 seen	 during	 5448AP	 infection,	 facilitating	
bacterial	dissemination.	GAS	can	survive	and	replicate	intracellularly	in	macrophages	(Barnett	et	




are	 generally	 used	 to	 filter	 bacteria,	 due	 to	 high	 concentrations	 of	 immune	 cells	 such	 as	































and	 iMOs	 following	 injection	with	saline,	5448	or	5448AP.	Future	studies	investigating	innate	




















and	 Kotb,	 2008).	 Virulence	 factors	 that	 contribute	 to	 invasive	 disease	 have	 been	 extensively	
researched,	 however	 there	 is	 an	 underrepresentation	 in	 the	 literature	 describing	 the	 host	
response	 to	 such	 infections.	 Contemporary	understanding	of	 infection	now	 leans	 towards	 the	
idea	that	host	immune	cells	can	greatly	influence	the	outcomes	of	disease,	where	pathways	such	
as	 cell	 death	 and	 signalling	 may	 have	 the	 potential	 to	 exacerbate	 infections	 and	 lead	 to	
unregulated	 inflammation	 (Lawrence	 et	 al.,	 2020).	 Neutrophils	 are	 the	 front	 line	 of	 innate	
immunity	 yet	 are	 well	 known	 for	 their	 ability	 to	 also	 cause	 damage	 to	 the	 host	 during	 an	
unregulated	 response	 (Epstein	 and	Weiss,	 1989).	 Understanding	 of	 the	 neutrophil-response	
during	invasive	GAS	infection	until	now	has	been	somewhat	limited.	This	thesis	aimed	to	optimise	
a	 method	 for	 the	 isolation	 of	 neutrophil	 proteins,	 appropriate	 for	 the	 evaluation	 of	 caspase	
activation	by	 immunoblotting	(Chapter	3).	Further,	 this	and	other	methods	were	employed	to	
characterise	the	human	neutrophil	response	to	emm98.1	and	emm1	GAS	in	vitro	(Chapters	4	and	
5).	 Finally,	 neutrophils	were	 characterised	 to	determine	 their	 role	 during	 a	murine	model	 of	
invasive	emm1	GAS	infection	(Chapter	6).	From	the	findings,	a	model	is	proposed	where	during	






Figure	 7.1:	 Theoretical	model	 of	 how	 infection	with	 GAS	 promotes	 an	 inflammatory	 neutrophil	
phenotype	and	contributes	to	the	severity	of	disease.	GAS	isolates	commonly	used	to	model	invasive	
disease	 induce	 inflammatory	 neutrophil	 death	 but	 display	 limited	 evidence	 of	 the	 induction	 of	 anti-
inflammatory	neutrophil	death.	During	inflammatory	neutrophil	death,	neutrophils	release	inflammatory	
cytokines	 and	 internal	 contents	 (danger	 associated	 molecular	 patterns	 (DAMPs)),	 further	 promoting	
neutrophil	 recruitment	 to	 the	 site	 of	 infection.	 GAS	 are	 resistant	 to	 neutrophil-mediated	 killing,	 and	
neutrophil	activation	and	antibacterial	activity	is	reduced.	Neutrophils	do	not	undergo	apoptosis,	rather	
have	prolonged	survival,	during	which	 time	GAS	 further	proliferate.	Dampened	signals	of	efferocytosis	













once	 isolated	 from	 blood	 (Miyoshi-Akiyama	 et	 al.,	 2005).	 For	 this	 reason	 and	 due	 to	 their	
abundance	 in	 circulation,	 neutrophils	 are	 an	 important	 research	 target.	 The	 effectiveness	 of	
neutrophils	 as	 phagocytes	 stems	 from	 the	 abundance	 of	 enzymes	 and	 antimicrobial	 peptides	
contained	within	their	granules	(Lim	et	al.,	2017).	These	granular	contents	are	released	upon	cell	
lysis,	 with	 the	 ensuing	 release	 of	 proteases	 hindering	 the	 study	 of	 intracellular	 neutrophil	
proteins.	This	thesis	has	optimised	a	reproducible	method	to	prepare	neutrophil	protein	lysates	





such	 as	 DNA	 transfection	 and	 transfusion,	 allowing	 the	 field	 of	 neutrophil	 biology	 to	 further	
progress.	
The	 field	 of	 cell	 death	 has	 expanded	 significantly	 in	 recent	 years,	 particularly	 in	 regards	 to	
understanding	 of	 inflammatory	 death	 pathways	 and	 their	 contribution	 to	 disease	 pathology	
(Lawrence	et	al.,	2020).	Inflammatory	neutrophil	death	was	first	reported	in	response	to	emm1	
GAS	(Kobayashi	et	al.,	2003a),	then	again	in	response	to	emm98.1	GAS	(Tsatsaronis	et	al.,	2015),	







inflammation,	 such	 as	 the	 release	 of	 interleukin	 (IL)-1β,	which	 results	 from	 the	 induction	 of	
inflammatory	death	pathways.	Although	gasdermin	D	(GSDMD)	is	considered	as	a	hallmark	of	
pyroptosis	 in	many	 cell	 types,	 it	 was	 not	 investigated	 in	 this	 study	 (Karmakar	 et	 al.,	 2020).	
Notably,	inflammatory	caspase	activation	in	response	to	emm1	GAS	did	not	directly	correlate	to	
amounts	of	IL-1β	release	from	human	neutrophils	or	in	mice,	unlike	what	was	seen	in	response	




























increased	 proliferation,	 rather	 than	 killing,	 in	 the	 presence	 of	 viable	 human	 neutrophils.	 It	 is	
hypothesised	 that	 for	covS	mutants,	multiple	 strains	may	 invoke	 an	 ‘invasive	phenotype’	 that	
disrupts	the	homeostatic	balance	required	for	infection	control.	The	identification	of	a	common	






Limited	 treatment	 options	 and	 swift	 progression	make	 invasive	 GAS	 infection	 a	 devastating	
disease	 and	 despite	 numerous	 efforts,	 vaccines	 that	 cover	 all	 GAS	 serotypes	 are	 still	 under	
development	(Davies	et	al.,	2019).	Thus,	a	more	comprehensive	understanding	of	the	immune	
response	 during	 invasive	 infection	 and	 the	 identification	 of	 early	 biomarkers	 may	 assist	 in	
broadening	 therapeutic	 options	 and	 decreasing	mortality.	 The	 characterisation	 of	 cells	 using	
expression	of	CD	markers	can	allow	for	the	identification	of	important	cell	subtypes	(Fine	et	al.,	
2019)	and	interpretation	of	cell	function	during	conditions	such	as	inflammation	(Lakschevitz	et	
al.,	 2016).	 CD11b	and	CD64	expression	on	neutrophils	have	both	been	 identified	 as	potential	
biomarkers	of	severe	inflammation	(Barth	et	al.,	2001,	Qiu	et	al.,	2019),	though	this	thesis	did	not	
confirm	these	findings	during	emm1	or	emm98.1	GAS	infection	of	neutrophils	in	vitro.	The	use	of	
CD	 molecules	 as	 biomarkers	 poses	 significant	 problems	 however,	 as	 over	 370	 are	 known.	
Therefore,	analysing	the	expression	of	only	one	or	two	markers	may	not	be	informative	across	a	
diversely	 heterogenetic	 population	 in	 a	 clinical	 setting.	 Tools	 such	 as	 high	 throughput	 flow	
cytometry	 may	 be	 more	 useful	 for	 a	 broader	 analysis	 of	 CD	 expression	 in	 a	 clinical	 setting	
















incubation	 with	 GAS.	 Similarly,	 the	 release	 of	 cytokines	 from	 GAS	 infected	 neutrophils	
predominantly	occurs	from	60	min	and	optimally	after	180	min	for	most	cytokines	analysed	here.	
Neutrophils	 are	known	to	 respond	 rapidly	 to	 infection	 (Serhan	et	 al.,	 2007),	 and	 in	 vivo	 data	
presented	confirms	that	neutrophil	viability	at	the	site	of	infection	is	low	by	24	h.	Therefore,	when	
investigating	neutrophil	function	(such	as	via	measurement	of	CD	expression),	neutrophils	may	
need	 to	 be	 assessed	 prior	 to	 this	 time	 point	 if	 viability	 is	 an	 important	 factor.	 The	 limited	
correlation	of	CD	expression	findings	between	the	human	in	vitro	and	mouse	in	vivo	work	could	
be	 a	 result	 of	 timing.	 Additionally,	 it	 cannot	 be	 excluded	 that	 differences	may	also	 be	 due	 to	
species-specific	 factors	 and	 the	 presence	 of	 a	 more	 complete	 immune	 response	 in	 vivo.	 One	












been	 limited	 by	 the	 number	 of	 biological	 replicates.	 Future	 experiments	 with	 additional	
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1500	and	200	µg/mL)	was	made	 in	corresponding	neutrophil	 lysis	buffer	 (	 see	Chapter	2)	and	protein	
concentrations	 of	 neutrophil	 lysates	 were	 determined	 using	 the	 DC	 Protein	 Assay	 (Bio-Rad)	 by	
determination	of	absorbance	at	750	nm	(A750)	(Lowry	et	al.,	1951).	Linear	and	cubic	models	were	compared	
and	 the	 cubic	 fit	 was	 applied	 for	 interpretation	 of	 unknown	 values	 (neutrophil	 lysate	 protein	
concentration).	Exemplary	curves	are	shown.
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C0.1	 0.00	 53.10	 <0.36	 52.65	 <0.36	 1.21	 -	
C0.2	 0.00	 52.20	 <0.36	 		 		 		 		
C1.1	 2.44	 58.50	 1.08	 64.80	 2.41	 13.75	 98.80	
C1.2	 2.44	 71.10	 3.89	 		 		 		 		
C2.1	 9.77	 83.70	 7.03	 97.20	 10.47	 19.64	 107.25	
C2.2	 9.77	 110.70	 13.90	 		 		 		 		
C3.1	 39.06	 198.90	 34.47	 203.40	 35.43	 3.13	 90.71	
C3.2	 39.06	 207.90	 36.39	 		 		 		 		
C4.1	 156.25	 1022.00	 154.86	 1076.00	 160.90	 7.09	 102.98	
C4.2	 156.25	 1130.00	 166.83	 		 		 		 		
C5.1	 625.00	 7358.00	 638.35	 7448.00	 644.22	 1.7	 103.08	
C5.2	 625.00	 7538.00	 650.08	 		 		 		 		
C6.1	 2500.00	 32057.00	 2491.51	 31515.00	 2439.74	 2.43	 97.59	
C6.2	 2500	 30974.00	 2388.71	 		 		 		 		
C7.1	 10000.00	 69845.00	 9992.33	 69971.00	 10043.29	 0.25	 100.43	
C7.2	 10000.00	 70097.00	 10094.59	 		 		 		 		
	
Table	 9.3:	 Standard	 curve	 for	 the	 calculation	 of	 cytokine	 (IL-1β)	 concentration	 using	 the	
LEGENDplex™	(BioLegend)	bead-based	flow	cytometric	assay	and	the	LEGENDplex™	software	V8.0.	
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neutrophils	 were	 incubated	 in	 the	 absence	 of	 antibody	 (unstained)	 or	 with	 1,	 3	 or	 5	 µL	 of	 antibody.	
Neutrophils	 were	 gated	 upon	 singlets	 then	 viable	 neutrophils	 and	 assessed	 for	 their	 respective	
fluorescence	by	flow	cytometry.	Data	were	used	to	select	an	appropriate	volume	for	cell	staining.
CD11b 




























FITC fluorescence PE/Cy7 fluorescence PE fluorescence 





























6	 Blood	 Saline	48M.fcs	 166473	 149346	 597	 537	 639	 563	 29	 14	
6	 Blood	 Saline	38F.fcs	 216014	 178483	 1980	 1923	 1225	 1142	 207	 90	
6	 Blood	 Saline	2M.fcs	 15037	 9049	 54	 51	 46	 40	 54	 41	
6	 Blood	 Saline	29F.fcs	 116207	 77297	 2042	 1910	 1715	 1085	 1604	 149	
6	 Blood	 Saline	26M.fcs	 148368	 118403	 683	 655	 516	 483	 55	 33	
6	 Blood	 Saline	25M.fcs	 232991	 197067	 3431	 2858	 1853	 1242	 640	 274	
6	 Blood	 Saline	14F.fcs	 135662	 112375	 1109	 1079	 733	 704	 27	 11	
6	 Blood	 Saline	13F.fcs	 102538	 75427	 764	 718	 382	 347	 172	 79	
6	 Blood	 5448	16F.fcs	 76480	 61306	 3369	 3324	 710	 671	 309	 159	
6	 Blood	 5448	20M.fcs	 80592	 48562	 6737	 4232	 2925	 1749	 530	 202	
6	 Blood	 5448	27F.fcs	 149356	 113083	 4979	 3933	 3041	 1954	 280	 81	
6	 Blood	 5448	28M.fcs	 28095	 19473	 1369	 1318	 1425	 1374	 21	 10	
6	 Blood	 5448	35F.fcs	 65173	 48915	 4080	 3903	 1798	 1628	 1823	 867	
















6	 Blood	 5448	43M.fcs	 44746	 35779	 2958	 2620	 809	 618	 913	 396	
6	 Blood	 5448	4M.fcs	 30742	 24360	 1701	 1576	 914	 836	 244	 178	
6	 Blood	 AP	18F.fcs	 68418	 57097	 10449	 10275	 1119	 994	 2270	 452	
6	 Blood	 AP	24M.fcs	 57922	 36898	 7633	 6888	 2589	 2158	 452	 210	
6	 Blood	 AP	30M.fcs	 41715	 34792	 2412	 2232	 1532	 1362	 35	 10	
6	 Blood	 AP	34F.fcs	 85535	 60360	 3287	 2591	 1143	 714	 1980	 190	
6	 Blood	 AP	37F.fcs	 66128	 55938	 5383	 5143	 1869	 1723	 1198	 362	
6	 Blood	 AP	42F.fcs	 94055	 80381	 15167	 15019	 11900	 11299	 363	 89	
6	 Blood	 AP	44M.fcs	 46098	 37977	 2499	 2190	 720	 569	 90	 30	
6	 Blood	 AP	6M.fcs	 49960	 40802	 4033	 3814	 1612	 1481	 826	 364	
24	 Blood	 Saline	8M.fcs	 210264	 168167	 1019	 971	 891	 861	 35	 17	
24	 Blood	 Saline	49M.fcs	 190604	 163175	 2931	 2618	 1254	 1044	 556	 180	
24	 Blood	 Saline	44F.fcs	 201880	 167056	 1988	 1879	 1587	 1491	 6043	 625	
24	 Blood	 Saline	42F.fcs	 230163	 188222	 1329	 1175	 1044	 810	 49	 16	
24	 Blood	 Saline	33F.fcs	 100172	 92200	 593	 566	 576	 561	 149	 121	
24	 Blood	 Saline	32M.fcs	 186113	 161457	 1516	 1435	 776	 736	 208	 88	

















24	 Blood	 Saline	20F.fcs	 215590	 173214	 1198	 1118	 839	 772	 410	 65	
24	 Blood	 5448	10M.fcs	 61108	 50329	 340	 282	 407	 348	 87	 31	
24	 Blood	 5448	22F.fcs	 43614	 32489	 446	 385	 538	 497	 2346	 625	
24	 Blood	 5448	22M.fcs	 19541	 14658	 127	 113	 109	 91	 119	 68	
24	 Blood	 5448	30F.fcs	 65439	 57181	 1135	 1119	 1649	 1552	 1581	 1352	
24	 Blood	 5448	34M.fcs	 52697	 40626	 871	 712	 2246	 2112	 362	 62	
24	 Blood	 5448	39F.fcs	 39149	 23715	 477	 412	 638	 497	 912	 204	
24	 Blood	 5448	46F.fcs	 43036	 28670	 375	 299	 467	 329	 1533	 220	
24	 Blood	 5448	46M.fcs	 28648	 20321	 183	 144	 238	 146	 79	 16	
24	 Blood	 AP	12M.fcs	 45202	 33111	 531	 491	 731	 656	 343	 146	
24	 Blood	 AP	23M.fcs	 504	 331	 6	 4	 0	 0	 2	 1	
24	 Blood	 AP	24F.fcs	 37780	 27885	 501	 400	 466	 401	 1816	 713	
24	 Blood	 AP	32F.fcs	 7096	 5006	 140	 125	 224	 218	 211	 65	
24	 Blood	 AP	36M.fcs	 62105	 45924	 282	 264	 1019	 950	 91	 34	
24	 Blood	 AP	41F.fcs	 42053	 27782	 383	 318	 823	 622	 269	 42	
24	 Blood	 AP	47M.fcs	 28490	 19622	 242	 212	 281	 197	 59	 16	
















6	 Lavage	 Saline	48M.fcs	 3196	 1537	 131	 124	 36	 24	 49	 11	
6	 Lavage	 Saline	38F.fcs	 2462	 1279	 597	 152	 407	 154	 56	 12	
6	 Lavage	 Saline	2M.fcs	 1507	 888	 122	 101	 61	 34	 78	 4	
6	 Lavage	 Saline	29F.fcs	 1722	 889	 88	 79	 69	 30	 86	 34	
6	 Lavage	 Saline	26M.fcs	 1420	 995	 50	 36	 38	 24	 27	 6	
6	 Lavage	 Saline	25M.fcs	 1348	 581	 12	 4	 46	 18	 76	 23	
6	 Lavage	 Saline	14F.fcs	 1128	 609	 17	 7	 53	 7	 115	 10	
6	 Lavage	 Saline	13F.fcs	 2330	 980	 18	 5	 15	 4	 47	 5	
6	 Lavage	 5448	16F.fcs	 11647	 8553	 8094	 6257	 2692	 1955	 144	 60	
6	 Lavage	 5448	20M.fcs	 4789	 1882	 2405	 1032	 742	 251	 110	 38	
6	 Lavage	 5448	27F.fcs	 1403	 626	 30	 10	 62	 24	 83	 30	
6	 Lavage	 5448	28M.fcs	 7551	 5688	 4327	 3561	 2189	 1731	 70	 26	
6	 Lavage	 5448	35F.fcs	 12867	 5601	 7460	 3459	 2730	 1333	 200	 79	
6	 Lavage	 5448	40F.fcs	 12083	 5805	 7293	 3862	 3974	 2286	 152	 90	
6	 Lavage	 5448	43M.fcs	 9017	 4591	 4680	 3194	 2154	 1436	 171	 97	
6	 Lavage	 5448	4M.fcs	 39760	 28009	 34691	 25244	 8363	 5626	 386	 201	

















6	 Lavage	 AP	24M.fcs	 2890	 796	 877	 129	 219	 40	 92	 29	
6	 Lavage	 AP	30M.fcs	 41779	 17195	 35223	 14030	 12775	 5526	 309	 186	
6	 Lavage	 AP	34F.fcs	 1919	 632	 280	 49	 130	 19	 87	 15	
6	 Lavage	 AP	37F.fcs	 6473	 2702	 2724	 1404	 753	 377	 85	 24	
6	 Lavage	 AP	42F.fcs	 92981	 59129	 83333	 54042	 37365	 26005	 1069	 746	
6	 Lavage	 AP	44M.fcs	 17473	 9915	 13409	 8260	 2159	 1111	 156	 72	
6	 Lavage	 AP	6M.fcs	 8344	 3923	 5448	 2745	 843	 333	 140	 28	
24	 Lavage	 Saline	8M.fcs	 1204	 940	 7	 5	 17	 6	 50	 11	
24	 Lavage	 Saline	49M.fcs	 4843	 1186	 72	 31	 50	 6	 63	 7	
24	 Lavage	 Saline	44F.fcs	 1086	 582	 24	 11	 13	 3	 36	 11	
24	 Lavage	 Saline	42F.fcs	 4872	 1216	 26	 8	 51	 11	 70	 11	
24	 Lavage	 Saline	33F.fcs	 0	 0	 0	 0	 0	 0	 0	 0	
24	 Lavage	 Saline	32M.fcs	 888	 575	 6	 5	 7	 3	 37	 13	
24	 Lavage	 Saline	26M.fcs	 1155	 596	 75	 42	 9	 4	 48	 26	
24	 Lavage	 Saline	20F.fcs	 1086	 817	 11	 2	 17	 5	 46	 10	
24	 Lavage	 5448	10M.fcs	 92300	 5477	 39319	 591	 8897	 102	 279	 21	
















24	 Lavage	 5448	22M.fcs	 229978	 33397	 115683	 7596	 8862	 261	 481	 104	
24	 Lavage	 5448	30F.fcs	 3687	 869	 1074	 138	 364	 26	 58	 23	
24	 Lavage	 5448	34M.fcs	 209180	 59005	 83350	 12104	 16071	 2405	 1813	 497	
24	 Lavage	 5448	39F.fcs	 30441	 1326	 5543	 172	 6792	 130	 181	 16	
24	 Lavage	 5448	46F.fcs	 124504	 7204	 67420	 2111	 16579	 599	 794	 39	
24	 Lavage	 5448	46M.fcs	 161018	 2596	 93722	 1031	 30774	 130	 612	 75	
24	 Lavage	 AP	12M.fcs	 10673	 800	 7111	 24	 2505	 5	 93	 7	
24	 Lavage	 AP	23M.fcs	 36982	 473	 33727	 51	 5520	 3	 152	 24	
24	 Lavage	 AP	24F.fcs	 29268	 1192	 23047	 98	 7698	 23	 78	 11	
24	 Lavage	 AP	32F.fcs	 4289	 843	 1982	 9	 389	 3	 76	 25	
24	 Lavage	 AP	36M.fcs	 26026	 571	 20214	 31	 6992	 2	 92	 19	
24	 Lavage	 AP	41F.fcs	 10282	 933	 5474	 7	 3935	 2	 131	 8	
24	 Lavage	 AP	47M.fcs	 16149	 736	 11912	 13	 8494	 3	 125	 5	
24	 Lavage	 AP	48F.fcs	 5508	 637	 2853	 16	 709	 4	 45	 7	
	
